<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults - Linde, M - 2013 | Cochrane Library</title> <meta content="Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults - Linde, M - 2013 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010611/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults - Linde, M - 2013 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010611/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010611" name="dc.identifier" scheme="DOI"/> <meta content="Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults" name="citation_title"/> <meta content="Mattias Linde" name="citation_author"/> <meta content="mattias.linde@ntnu.no" name="citation_author_email"/> <meta content="Wim M Mulleners" name="citation_author"/> <meta content="Canisius Wilhelmina Ziekenhuis" name="citation_author_institution"/> <meta content="Edward P Chronicle" name="citation_author"/> <meta content="University of Hawaii at Manoa" name="citation_author_institution"/> <meta content="Douglas C McCrory" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="6" name="citation_issue"/> <meta content="10.1002/14651858.CD010611" name="citation_doi"/> <meta content="2013" name="citation_date"/> <meta content="2013/06/24" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010611/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010611/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010611/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anticonvulsants [*therapeutic use]; Flunarizine [therapeutic use]; Fructose [analogs &amp; derivatives, therapeutic use]; Migraine Disorders [*prevention &amp; control]; Propranolol [therapeutic use]; Randomized Controlled Trials as Topic; Topiramate; Valproic Acid [*therapeutic use]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010611&amp;doi=10.1002/14651858.CD010611&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010611&amp;doi=10.1002/14651858.CD010611&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010611&amp;doi=10.1002/14651858.CD010611&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010611&amp;doi=10.1002/14651858.CD010611&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010611&amp;doi=10.1002/14651858.CD010611&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010611&amp;doi=10.1002/14651858.CD010611&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010611&amp;doi=10.1002/14651858.CD010611&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010611&amp;doi=10.1002/14651858.CD010611&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010611&amp;doi=10.1002/14651858.CD010611&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010611&amp;doi=10.1002/14651858.CD010611&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010611&amp;doi=10.1002/14651858.CD010611&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010611&amp;doi=10.1002/14651858.CD010611&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010611&amp;doi=10.1002/14651858.CD010611&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010611&amp;doi=10.1002/14651858.CD010611&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010611&amp;doi=10.1002/14651858.CD010611&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010611&amp;doi=10.1002/14651858.CD010611&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010611&amp;doi=10.1002/14651858.CD010611&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010611&amp;doi=10.1002/14651858.CD010611&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010611&amp;doi=10.1002/14651858.CD010611&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010611&amp;doi=10.1002/14651858.CD010611&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010611&amp;doi=10.1002/14651858.CD010611&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010611&amp;doi=10.1002/14651858.CD010611&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010611&amp;doi=10.1002/14651858.CD010611&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="f00EizoA";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010611\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010611\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010611\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010611\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ko","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010611",title:"Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults",firstPublishedDate:"Jun 24, 2013 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pain, Palliative and Supportive Care Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=f00EizoA&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010611&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010611';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010611/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010611/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010611%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010611/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010611/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010611/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010611/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010611" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010611/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010611" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010611/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010611/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>13750 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010611" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010611/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010611/full#CD010611-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010611/full#CD010611-sec-0083"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010611/full#CD010611-sec-0029"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010611/full#CD010611-sec-0034"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010611/full#CD010611-sec-0035"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010611/full#CD010611-sec-0052"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010611/full#CD010611-sec-0073"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010611/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010611/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010611/appendices#CD010611-sec-0088"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010611/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010611/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/table_n/CD010611StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/table_n/CD010611StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010611/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010611/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010611/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010611/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010611/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010611/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2016 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010611/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010611/information#CD010611-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Mattias Linde</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010611/information#CD010611-cr-0003">Wim M Mulleners</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010611/information#CD010611-cr-0004">Edward P Chronicle</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010611/information#CD010611-cr-0005">Douglas C McCrory</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010611/information/en#CD010611-sec-0103">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 24 June 2013 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010611/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010611">https://doi.org/10.1002/14651858.CD010611</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010611-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010611-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010611-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010611-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010611-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD010611-abs-0002">한국어</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010611-abs-0001" lang="en"> <section id="CD010611-sec-0001"> <h3 class="title" id="CD010611-sec-0001">Background</h3> <p>Some antiepileptic drugs but not others are useful in clinical practice for the prophylaxis of migraine. This might be explained by the variety of actions of these drugs in the central nervous system. The present review is part of an update of a Cochrane review first published in 2004, and previously updated (conclusions not changed) in 2007. </p> </section> <section id="CD010611-sec-0002"> <h3 class="title" id="CD010611-sec-0002">Objectives</h3> <p>To describe and assess the evidence from controlled trials on the efficacy and tolerability of valproate (valproic acid or sodium valproate or a combination of the two) for preventing migraine attacks in adult patients with episodic migraine. </p> </section> <section id="CD010611-sec-0003"> <h3 class="title" id="CD010611-sec-0003">Search methods</h3> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL; <i>The Cochrane Library</i> 2012, Issue 12), PubMed/MEDLINE (1966 to 15 January 2013), MEDLINE In‐Process (current week, 15 January 2013), and EMBASE (1974 to 15 January 2013) and handsearched <i>Headache</i> and <i>Cephalalgia</i> through January 2013. </p> </section> <section id="CD010611-sec-0004"> <h3 class="title" id="CD010611-sec-0004">Selection criteria</h3> <p>Studies were required to be prospective, controlled trials of valproate taken regularly to prevent the occurrence of migraine attacks, to improve migraine‐related quality of life, or both. </p> </section> <section id="CD010611-sec-0005"> <h3 class="title" id="CD010611-sec-0005">Data collection and analysis</h3> <p>Two review authors independently selected studies and extracted data. For headache frequency data, we calculated mean differences (MDs) between valproate and comparator (placebo, active control, or valproate in a different dose) for individual studies and pooled these across studies. For dichotomous data on responders (patients with ≥ 50% reduction in headache frequency), we calculated odds ratios (ORs) and, in select cases, risk ratios (RRs); we also calculated numbers needed to treat (NNTs). We calculated MDs for Migraine Disability Assessment (MIDAS) scores. We also summarised data on adverse events from placebo‐controlled trials and calculated risk differences (RDs) and numbers needed to harm (NNHs). </p> </section> <section id="CD010611-sec-0006"> <h3 class="title" id="CD010611-sec-0006">Main results</h3> <p>Ten papers describing 10 unique trials met the inclusion criteria. Analysis of data from two trials (63 participants) showed that sodium valproate reduced headache frequency by approximately four headaches per 28 days as compared to placebo (MD ‐4.31; 95% confidence interval (CI) ‐8.32 to ‐0.30). Data from four trials (542 participants) showed that divalproex sodium (a stable combination of sodium valproate and valproic acid in a 1:1 molar ratio) more than doubled the proportion of responders relative to placebo (RR 2.18; 95% CI 1.28 to 3.72; NNT 4; 95% CI 2 to 11). One study of sodium valproate (34 participants) versus placebo supported the latter findings (RR for responders 2.83; 95% CI 1.27 to 6.31; NNT 3; 95% CI 2 to 9). There was no significant difference in the proportion of responders between sodium valproate versus flunarizine (one trial, 41 participants) or between divalproex sodium versus propranolol (one trial, 32 participants). Pooled analysis of post‐treatment mean headache frequencies in two trials (88 participants) demonstrates a slight but significant advantage for topiramate 50 mg over valproate 400 mg (MD ‐0.90; 95% CI ‐1.58 to ‐0.22). For placebo‐controlled trials of sodium valproate and divalproex sodium, NNHs for clinically important adverse events ranged from 7 to 14. </p> </section> <section id="CD010611-sec-0007"> <h3 class="title" id="CD010611-sec-0007">Authors' conclusions</h3> <p>Valproate is effective in reducing headache frequency and is reasonably well tolerated in adult patients with episodic migraine. </p> </section> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010611-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010611-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010611-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010611-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010611-abs-0006">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD010611-abs-0005">한국어</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010611-abs-0004" lang="en"> <h3>Valproate for preventing migraine attacks in adults</h3> <p>Various medicines, collectively termed 'antiepileptics', are used to treat epilepsy. For several years, some of these drugs have also been used for preventing migraine attacks. For the present review, researchers in The Cochrane Collaboration reviewed the evidence about the effects of valproate (valproic acid or sodium valproate or a combination of the two) in adult patients (≥ 16 years of age) with 'episodic' migraine (headache on &lt; 15 days per month). They examined research published up to 15 January 2013 and found 10 relevant studies. Compared with placebo, valproate reduced the frequency of migraine headaches by approximately four per month (two studies, 63 participants). Patients were also more than twice as likely to reduce the number of their migraine headaches by 50% or more with valproate than with placebo (five studies, 576 participants). Side effects associated with valproate were common but generally mild; valproate can, however, cause birth defects and so should be used with caution in women of childbearing age. Further research is needed comparing valproate with other active drugs used for preventing migraine attacks. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010611-sec-0083" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010611-sec-0083"></div> <h3 class="title" id="CD010611-sec-0084">Implications for practice</h3> <section id="CD010611-sec-0084"> <p>Bearing in mind the limitations invoked by the methodological and reporting issues mentioned above, this review nevertheless helps to provide a rational framework for the application of valproate for the preventive management of migraine headache in clinical practice. Valproate has been investigated in 10 independent clinical trials, the results of which are generally consistent. It can be concluded from this review that valproate is of proven efficacy in migraine prevention and is suitable for routine clinical use. It must be stressed, however, that this review does not provide definite evidence for the efficacy of valproate in the management of other aspects of the condition (eg, prodromal symptoms, aura symptoms). Likewise, the conclusions in this review cannot be extrapolated to chronic migraine, transformed migraine, or chronic daily headache. None of these conditions was considered for this review, as properly validated definitions are as yet lacking. </p> <p>Although adverse events were reported by a large proportion of migraine patients treated with valproate, these were usually mild and of a non‐serious nature. Thus it can be concluded that valproate is reasonably well tolerated. One important caveat should be noted: valproate is known to be teratogenic (<a href="./references#CD010611-bbs2-0050" title="MorrellMJ . Reproductive and metabolic disorders in women with epilepsy. Epilepsia2003;44 Suppl 4:11‐20. ">Morrell 2003</a>), and appropriate caution must accordingly be used when prescribing to women of childbearing age. </p> </section> <h3 class="title" id="CD010611-sec-0085">Implications for research</h3> <section id="CD010611-sec-0085"> <p>There is a need for more studies designed specifically to compare the efficacy or safety of valproate to other interventions with proven efficacy in the prophylaxis of migraine. Also needed are (a) better studies of dose versus effect; (b) studies of which patients do and do not respond, and why; (c) long‐term studies; and (d) studies post‐withdrawal of valproate after effective use for several months. </p> <p>Future trialists should also be encouraged to follow the recommendations of the International Headache Society (<a href="./references#CD010611-bbs2-0056" title="Tfelt‐HansenP , PascualJ , RamadanN , DahlöfC , D'AmicoD , DienerHC , et al. International Headache Society Clinical Trials Subcommittee. Guidelines for controlled trials of drugs in migraine: third edition. A guide for investigators. Cephalalgia2012;32(1):6‐38. [MEDLINE: 22384463] ">Tfelt‐Hansen 2012</a>) with regard to both trial design and reporting of data. </p> <p>Little is definitely known about the mechanism of action of valproate in migraine prophylaxis. A considerable amount of basic science research in both animal models and human neuroscience laboratories will be necessary in order to discover which of the many potential actions of this drug are causative in the reduction of headache frequency. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010611-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD010611-sec-0029"></div> <section id="CD010611-sec-0030"> <h3 class="title" id="CD010611-sec-0030">Description of the condition</h3> <p>Migraine is a common and disabling health problem among children and predominantly young and middle‐aged adults. Surveys from the main regions of the world suggest that the global prevalence of migraine is 14.7% (18.8% among women and 10.7% among men) (<a href="./references#CD010611-bbs2-0038" title="VosT , FlaxmanAD , NaghaviM , LozanoR , MichaudC , EzzatiM , et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990‐2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet2013;380(9859):2163‐96. [MEDLINE: 23245607] ">GBD 2010 Study</a>). This disorder results in significant disability and work loss, and several studies have addressed the issue of the costs of migraine. In one of the most recent publications, aggregate direct and indirect costs to society due to migraine among adults in the European Union were estimated to amount to 50 billion Euros (67 billion US dollars) annually, or about 1222 Euros (1634 US dollars) annually per sufferer (<a href="./references#CD010611-bbs2-0043" title="LindeM , GustavssonA , StovnerLJ , SteinerTJ , BarréJ , KatsaravaZ , et al. The cost of headache disorders in Europe: the Eurolight project. European Journal of Neurology2012;19(5):703‐11. [MEDLINE: 22136117] ">Linde 2012</a>). </p> </section> <section id="CD010611-sec-0031"> <h3 class="title" id="CD010611-sec-0031">Description of the intervention</h3> <p>Drug therapy for migraine falls into two categories: acute and preventive. Acute therapy aims at the symptomatic treatment of the head pain and other symptoms associated with an acute attack of migraine. The primary goals of preventive treatment are to reduce attack frequency, severity, and duration. Moreover, such therapy is commonly employed in an attempt to improve responsiveness to acute treatment, enhance functional status, and reduce disability. Evidence‐based guidelines on the drug treatment of migraine have been developed and published by the European Federation of Neurological Societies (EFNS; <a href="./references#CD010611-bbs2-0037" title="EversS , AfraJ , FreseA , GoadsbyPJ , LindeM , MayA , et al. European Federation of Neurological Societies. EFNS guideline on the drug treatment of migraine—revised report of an EFNS task force. European Journal of Neurology2009;16(9):968‐81. [MEDLINE: 19708964] ">Evers 2009</a>). These guidelines suggest that prophylactic therapy should be considered for patients with migraine when quality of life, business duties, or school attendance are severely impaired; when the frequency of attacks is two or more per month; when there is a lack of response to acute drug treatment; and when frequent, very long, or uncomfortable auras occur. </p> <p>This review considers the evidence for the efficacy and tolerability of valproate for preventing episodic migraine in adults. The prophylactic treatment of migraine in children is the subject of a separate Cochrane review (<a href="./references#CD010611-bbs2-0057" title="VictorS , RyanS . Drugs for preventing migraine headaches in children. Cochrane Database of Systematic Reviews2003, Issue 4. [DOI: 10.1002/14651858.CD002761] ">Victor 2003</a>). </p> <p>Valproic acid (2‐Propylpentanoic acid) was first synthesised in 1882 as analogue of valeric acid, found naturally in valerian. It is a liquid at room temperature, but it can be reacted with a base such as sodium hydroxide to form the salt sodium valproate, which is solid. Valproic acid, sodium valproate, or a mixture of the two (divalproex sodium according to United States Adopted Names (USAN), valproate semisodium according to WHO International Nonproprietary Name (INN) nomenclature) are marketed under various brand names and are collectively referred to as 'valproate' in this review. </p> <p>Sodium valproate is rapidly absorbed, reaching peak plasma concentrations within one to four hours and thereafter remaining stable for four to 14 hours. After oral administration, 85% to 100% of the administered dose is absorbed. Half‐life is eight to 20 hours in most patients, but may occasionally be much longer. Renal impairment prolongs the half‐life. The relationship between dose, plasma concentration, and effect are incompletely understood. The equilibrium concentration is usually achieved after three to five days of treatment. Sodium valproate is highly protein bound (approximately 90%). The concentration in the cerebrospinal fluid is approximately 10% of plasma concentrations. Sodium valproate is extensively metabolised and excreted in the urine as conjugated metabolites. </p> </section> <section id="CD010611-sec-0032"> <h3 class="title" id="CD010611-sec-0032">How the intervention might work</h3> <p>We use the term 'antiepileptics' here to refer generally to those drugs in common use for the treatment of epilepsy. The pharmacological treatment of epilepsy can be traced back as far as 1857, but the period of greatest development of antiepileptics was between 1935 and 1960, when 13 drugs were developed and marketed (<a href="./references#CD010611-bbs2-0052" title="PorterRJ , MeldrumBS . Antiepileptic drugs. In: KatzungBG editor(s). Basic and Clinical Pharmacology. 5th Edition. Norwalk, CT: Appleton &amp; Lange, 1992:331‐49. ">Porter 1992</a>). In recent decades, renewed interest has led to the development of several novel antiepileptics which may confer advantages in tolerability (<a href="./references#CD010611-bbs2-0034" title="DalkaraS , KarakurtA . Recent progress in anticonvulsant drug research: strategies for anticonvulsant drug development and applications of antiepileptic drugs for non‐epileptic central nervous system disorders. Current Topics in Medicinal Chemistry2012;12(9):1033‐71. [MEDLINE: 22352861] ">Dalkara 2012</a>), and these are beginning to be used in migraine also. </p> <p>The use of antiepileptics for the prophylactic treatment of migraine is theoretically warranted by several known modes of action which relate either to the general modulation of pain systems or more specifically to systems involved in the pathophysiology of migraine (<a href="./references#CD010611-bbs2-0054" title="SilbersteinS , SaperJ , BerensonF , SomogyiM , McCagueK , D'SouzaJ . Oxcarbazepine in migraine headache: a double‐blind, randomized, placebo‐controlled study. Neurology2008;70(7):548‐55. [MEDLINE: 18268247] ">Silberstein 2008</a>; <a href="./references#CD010611-bbs2-0058" title="WiffenPJ , CollinsS , McQuayHJ , CarrollD , JadadA , MooreRA . Anticonvulsant drugs for acute and chronic pain. Cochrane Database of Systematic Reviews2010, Issue 1. [DOI: 10.1002/14651858.CD001133.pub3] ">Wiffen 2010</a>). The mechanisms of action of valproate include enhanced neurotransmission of GABA (by inhibiting GABA transaminase) and blockage of voltage‐gated sodium channels and T‐type calcium channels. More than 15 years ago, Cutrer and colleagues identified nine stages of the migraine attack at which valproate might potentially have a beneficial effect (<a href="./references#CD010611-bbs2-0033" title="CutrerFM , LimmrothV , MoskowitzMA . Possible mechanisms of valproate in migraine prophylaxis. Cephalalgia1997;17(2):93‐100. ">Cutrer 1997</a>), but it is still not possible to state with certainty which particular mode or modes of action of valproate are relevant to the prophylaxis of migraine. </p> </section> <section id="CD010611-sec-0033"> <h3 class="title" id="CD010611-sec-0033">Why it is important to do this review</h3> <p>Some antiepileptic drugs are marketed specifically for migraine prophylaxis, and divalproex sodium has been approved by the US Food and Drug Administration (FDA) for migraine prophylaxis since 1996. The EFNS (<a href="./references#CD010611-bbs2-0037" title="EversS , AfraJ , FreseA , GoadsbyPJ , LindeM , MayA , et al. European Federation of Neurological Societies. EFNS guideline on the drug treatment of migraine—revised report of an EFNS task force. European Journal of Neurology2009;16(9):968‐81. [MEDLINE: 19708964] ">Evers 2009</a>) and the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society (<a href="./references#CD010611-bbs2-0055" title="SilbersteinSD , HollandS , FreitagF , DodickDW , ArgoffC , AshmanE , Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Evidence‐based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology2012;78(17):1337‐45. [MEDLINE: 22529202] ">Silberstein 2012</a>) list valproic acid among first‐line migraine prophylactics. </p> <p>There is a fairly substantial body of evidence from controlled trials supporting the efficacy of many of the agents used for preventing migraine, yet such therapies are used by only a small percentage of patients with migraine — 3% to 12% in various studies (<a href="./references#CD010611-bbs2-0032" title="ClarkeCE , MacMillanL , SondhiS , WellsNE . Economic and social impact of migraine. QJM1996;89(1):77‐84. [MEDLINE: 8730346] ">Clarke 1996</a>; <a href="./references#CD010611-bbs2-0035" title="EdmeadsJ , FindlayH , TugwellP , Pryse‐PhillipsW , NelsonRF , MurrayTJ . Impact of migraine and tension‐type headache on life‐style, consulting behaviour, and medication use: a Canadian population survey. Canadian Journal of Neurological Sciences1993;20(2):131‐7. [MEDLINE: 8334575] ">Edmeads 1993</a>; <a href="./references#CD010611-bbs2-0049" title="MehuysE , PaemeleireK , VanHeesT , ChristiaensT , VanBortelLM , VanTongelenI , et al. Self‐medication of regular headache: a community pharmacy‐based survey. European Journal of Neurology2012;19(8):1093‐9. [MEDLINE: 22360745] ">Mehuys 2012</a>). It is hoped that this review and others like it will increase awareness of migraine prophylactic treatment options and help to provide a systematic basis for making the best possible choice of such therapy in those individuals in need of it. </p> <p>The present review is part of a series of reviews which, taken together, represent an update of a Cochrane review on 'Anticonvulsant drugs for migraine prophylaxis' (<a href="./references#CD010611-bbs2-0059" title="ChronicleEP , MullenersWM . Anticonvulsant drugs for migraine prophylaxis. Cochrane Database of Systematic Reviews2004, Issue 3. [DOI: 10.1002/14651858.CD003226.pub2] ">Chronicle 2004</a>; <a href="./references#CD010611-bbs2-0060" title="MullenersWM , ChronicleEP . Anticonvulsants in migraine prophylaxis: a Cochrane review. Cephalalgia2008;28(6):585‐97. [MEDLINE: 18454787] ">Mulleners 2008</a>; first published in 2004, and previously updated (conclusions not changed) in 2007). The old review has been split into four separate reviews for updating: </p> <p> <ol id="CD010611-list-0001"> <li> <p>Topiramate for the prophylaxis of episodic migraine in adults (<a href="./references#CD010611-bbs2-0044" title="LindeM , MullenersWM , ChronicleEP , McCroryDC . Topiramate for the prophylaxis of episodic migraine in adults. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD010610] ">Linde 2013a</a>) </p> </li> <li> <p>Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults (the present review, <a href="./references#CD010611-bbs2-0045" title="LindeM , MullenersWM , ChronicleEP , McCroryDC . Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD010611] ">Linde 2013b</a>) </p> </li> <li> <p>Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults (<a href="./references#CD010611-bbs2-0046" title="LindeM , MullenersWM , ChronicleEP , McCroryDC . Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD010609] ">Linde 2013c</a>) </p> </li> <li> <p>Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for the prophylaxis of episodic migraine in adults (<a href="./references#CD010611-bbs2-0047" title="LindeM , MullenersWM , ChronicleEP , McCroryDC . Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for the prophylaxis of episodic migraine in adults. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD010608] ">Linde 2013d</a>) </p> </li> </ol> </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010611-sec-0034" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010611-sec-0034"></div> <p>To describe and assess the evidence from controlled trials on the efficacy and tolerability of valproate (valproic acid or sodium valproate or a combination of the two) for preventing migraine attacks in adult patients with episodic migraine. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010611-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010611-sec-0035"></div> <section id="CD010611-sec-0036"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010611-sec-0037"> <h4 class="title">Types of studies</h4> <p>The International Headache Society (IHS) has provided a useful document setting out guidelines for the conduct of clinical trials in migraine, to which current investigators are encouraged to adhere (<a href="./references#CD010611-bbs2-0056" title="Tfelt‐HansenP , PascualJ , RamadanN , DahlöfC , D'AmicoD , DienerHC , et al. International Headache Society Clinical Trials Subcommittee. Guidelines for controlled trials of drugs in migraine: third edition. A guide for investigators. Cephalalgia2012;32(1):6‐38. [MEDLINE: 22384463] ">Tfelt‐Hansen 2012</a>). This document was not used as the sole basis for considering studies in this review, as too many potentially informative past studies would likely have been excluded on methodological grounds. However, many of its recommendations have been used as a basis for what follows. </p> <p>Included studies were required to be prospective, controlled trials of self administered valproate (valproic acid or sodium valproate or a combination of the two) taken regularly to prevent the occurrence of migraine attacks, to improve migraine‐related quality of life, or both. We included trials only if allocation to treatment groups was randomised or pseudo‐randomised (based on some non‐random process unrelated to the treatment selection or expected response). Blinding was not required. We excluded concurrent cohort comparisons and other non‐experimental designs. </p> </section> <section id="CD010611-sec-0038"> <h4 class="title">Types of participants</h4> <p>Study participants were required to be adults (at least 16 years of age) and to meet reasonable criteria designed to distinguish migraine from tension‐type headache. If patients with both types of headache were included in a trial, results were required to be stratified by headache diagnosis. We did not require the use of a specific set of diagnostic criteria (eg, <a href="./references#CD010611-bbs2-0030" title="Ad Hoc Committee on the Classification of Headache of the National Institute of Neurological Diseases and Blindness. Classification of headache. JAMA1962;179(9):717‐8. ">Ad Hoc Cttee 1962</a>; <a href="./references#CD010611-bbs2-0040" title="Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia1988;8 Suppl 7:1‐96. ">IHS Cttee 1988</a>; <a href="./references#CD010611-bbs2-0039" title="Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia2004;24 Suppl 1:1‐160. ">ICHD‐II 2004</a>), but migraine diagnoses had to be based on at least some of the distinctive features of migraine, eg, nausea/vomiting, severe head pain, throbbing character, unilateral location, phono/photophobia, or aura. Secondary headache disorders had to be excluded using reasonable criteria. </p> <p>We anticipated that some of the trials identified would include patients described as having mixed migraine and tension‐type headaches or combination headaches, and the protocol for this review described detailed procedures for dealing with such trials. In the end, no such precautions were necessary. We excluded studies evaluating treatments for chronic daily headache, chronic migraine, and transformed migraine. The reasons for this are: (a) the definition of chronic migraine is still heavily debated, and a revision of the 2004 IHS criteria for this condition has been proposed (<a href="./references#CD010611-bbs2-0051" title="OlesenJ , BousserM‐G , DienerH‐C , DodickD , FirstM , GoadsbyPJ , et al. Headache Classification Committee. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia2006;26(6):742‐6. [MEDLINE: 16686915] ">Olesen 2006</a>); (b) transformed migraine and chronic daily headache, although commonly used terms, are insufficiently validated diagnoses; (c) the separation of these conditions from headache due to medication overuse is not always clear in many studies; and (d) there is some evidence that suggests that chronic migraine may be more refractory to standard prophylactic treatment than episodic migraine. We explicitly excluded trials and treatment groups including only patients with tension‐type headache. </p> </section> <section id="CD010611-sec-0039"> <h4 class="title">Types of interventions</h4> <p>Included studies were required to have at least one arm in which valproate (valproic acid or sodium valproate or combination of the two, without concomitant use of other migraine prophylactic treatment) was given regularly during headache‐free intervals with the aim of preventing the occurrence of migraine attacks, improving migraine‐related quality of life, or both. Acceptable comparator groups included placebo, no intervention, active drug treatment (ie, with proven efficacy, not experimental), the same drug treatment with a clinically relevant different dose, and non‐pharmacological therapies with proven efficacy in migraine. The analysis included only drugs and dosages that are commercially available. </p> <p>We recorded any data reported on treatment compliance in the <a href="./references#CD010611-sec-0110" title="">Characteristics of included studies</a> table. After examination of these data, it did not seem necessary to stratify the analysis by compliance. </p> <p>We anticipated that most trials would permit the use of medication for acute migraine attacks experienced during the trial period. We therefore recorded descriptions of trial rules concerning the use of acute medication in the <a href="./references#CD010611-sec-0110" title="">Characteristics of included studies</a> table whenever such information was provided. We did not otherwise model or adjust for this factor in our analysis. </p> </section> <section id="CD010611-sec-0040"> <h4 class="title">Types of outcome measures</h4> <p>We collected and analysed trial data on headache frequency, responders (patients with ≥ 50% reduction in headache frequency), quality of life, and adverse events. </p> </section> </section> <section id="CD010611-sec-0041"> <h3 class="title">Search methods for identification of studies</h3> <p>Search strategies used in our earlier review (<a href="./references#CD010611-bbs2-0059" title="ChronicleEP , MullenersWM . Anticonvulsant drugs for migraine prophylaxis. Cochrane Database of Systematic Reviews2004, Issue 3. [DOI: 10.1002/14651858.CD003226.pub2] ">Chronicle 2004</a>; <a href="./references#CD010611-bbs2-0060" title="MullenersWM , ChronicleEP . Anticonvulsants in migraine prophylaxis: a Cochrane review. Cephalalgia2008;28(6):585‐97. [MEDLINE: 18454787] ">Mulleners 2008</a>) are detailed in <a href="./appendices#CD010611-sec-0089">Appendix 1</a> (last search date 31 December 2005). For the present update, trained information specialists developed detailed search strategies for each database searched (<a href="./appendices#CD010611-sec-0096">Appendix 2</a>). The new searches overlapped the old searches by a full year to ensure complete coverage. The last search date for all updated searches was 15 January 2013. </p> <p>Databases searched for this update were:</p> <p> <ul id="CD010611-list-0002"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; <i>The Cochrane Library</i> 2012, Issue 12; years searched = 2005 to 2012); </p> </li> <li> <p>MEDLINE (via OVID), 2005 to 15 January 2013;</p> </li> <li> <p>MEDLINE In‐Process (via OVID), current week, 15 January 2013;</p> </li> <li> <p>EMBASE (via OVID), 2005 to 15 January 2013.</p> </li> </ul> </p> <p>Additional strategies for identifying trials included searching the reference lists of review articles and included studies, searching books related to headache, and consulting experts in the field. We attempted to identify all relevant published trials, irrespective of language. We handsearched two journals, <i>Headache</i> and <i>Cephalalgia</i>, in their entirety through January 2013. </p> </section> <section id="CD010611-sec-0042"> <h3 class="title" id="CD010611-sec-0042">Data collection and analysis</h3> <section id="CD010611-sec-0043"> <h4 class="title">Selection of studies</h4> <p>Two of us independently screened titles and abstracts of studies identified by the literature search for eligibility. Papers that could not be excluded with certainty on the basis of information contained in the title and/or abstract were retrieved in full for screening. Disagreements were resolved through discussion. We retrieved papers passing this initial screening process, and two of us independently reviewed the full texts. Disagreements at the full‐text stage were resolved through internal discussion and, in a few cases, through correspondence with members of the editorial staff of the Cochrane Pain, Palliative and Supportive Care Review Group. We were not blinded to study investigators' names and institutions, journal of publication, or study results at any stage of the review. </p> <p>The search strategy described above identified a large number of short conference and journal abstracts. The majority of these either (a) reported partial results of ongoing trials; (b) provided insufficient information on trial design or results; (c) were early reports of included studies; or (d) were reproductions of abstracts of papers published in full (for example, the journal <i>Headache</i> reproduces abstracts of interest to readers, and these are found by PubMed). We agreed that short abstracts of this kind would be excluded from consideration. </p> </section> <section id="CD010611-sec-0044"> <h4 class="title">Data extraction and management</h4> <p>Two of us independently abstracted information on patients, methods, interventions, efficacy outcomes, and adverse events from the original reports onto specially designed, pre‐tested paper forms. Disagreements were again resolved through discussion. </p> <p>We anticipated that trials would vary in length, that outcomes would be measured over various units of time (eg, number of attacks per two weeks versus number of attacks per four weeks), and that results would be reported for numerous different time points (eg, four‐week headache frequency at two months versus at four months). We attempted to standardise the unit of time over which headache frequency was measured at 28 days (four weeks) wherever possible. We recorded outcomes beginning four weeks after the start of treatment and continued through all later assessment periods. We made decisions about which time points to include in the final analysis once the data had been collected. </p> <p>We anticipated that outcomes measured on a continuous scale (eg, headache frequency) would be reported in a variety of ways, eg, as mean pre‐treatment, post‐treatment, and/or change scores. Among change scores, we preferred the mean of within‐patient changes (from baseline to on‐treatment in a parallel‐group trial) over the change in group means because the first both results in a lower variance (taking into account the correlation between baseline and post‐treatment scores in each patient) and adjusts for imbalances in baseline headache frequencies, while the latter has only the second advantage. When neither type of change score was reported, we compared post–treatment means between groups, assuming that baseline data would be balanced due to randomisation. We anticipated that many trials would report group means, without reporting data on the variance associated with these means. In such cases, we attempted to calculate or estimate variances based on primary data, test statistics, and/or error bars in graphs. </p> <p>When efficacy outcomes were reported in dichotomous form (success/failure), we required that the threshold for distinguishing between treatment success and failure be clinically significant; for example, we interpreted a ≥ 50% reduction in headache frequency as meeting this criterion. In such cases, we recorded, for each treatment arm, the number of patients included in the analysis and the number with each outcome. </p> <p>The protocol for this review specified rules for dealing with outcome data reported on an ordinal scale (eg, for reduction in headache frequency: 0%, 1% to 24%, 25% to 49%, 50% to 74%, 75% to 99%, 100%) but, in fact, none of the included trials reported ordinal data for outcomes of interest. </p> <p>We envisaged that the preferred methods of collecting and presenting data on quality of life would most likely be the Migraine‐Specific Questionnaire (MSQ) and the Medical Outcomes Study 36‐item Short‐Form Health Survey (SF‐36). However, other instruments and other types of outcomes related to quality of life (eg, work absenteeism) were not excluded a priori, and these data were kept under review before specifying rules for analysing outcome data in this domain. </p> <p>We recorded the proportion of patients reporting adverse events for each treatment arm wherever possible. The identity and rates of specific adverse events were also recorded. We anticipated that reporting of adverse events would vary greatly across trials with regard to the terminology used, method of ascertainment, and classification of adverse events as drug‐related or not and as severe or not. </p> </section> <section id="CD010611-sec-0045"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We completed a 'Risk of bias' table for each study, using assessments of random sequence generation (selection bias), allocation concealment (selection bias), blinding of participants and personnel (performance bias), blinding of outcome assessment (detection bias), incomplete outcome data (attrition bias), and selective reporting (reporting bias). For new studies identified in the present update, two of us completed this assessment independently; for older studies, one of us performed the assessment and a second author reviewed and commented on it. Disagreements were resolved through discussion. </p> <p>We also assessed the methodological quality of individual trials using the scale devised by Jadad and colleagues (<a href="./references#CD010611-bbs2-0041" title="JadadAR , MooreRA , CarrollD , JenkinsonC , ReynoldsDJ , GavaghanDJ , et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials1996;17(1):1‐12. [MEDLINE: 8721797] ">Jadad 1996</a>), operationalised as follows: </p> <p> <ol id="CD010611-list-0003"> <li> <p>Was the study described as randomised? (1 = yes; 0 = no)</p> </li> <li> <p>Was the method of randomisation well described and adequate? (0 = not described; 1 = described and adequate; ‐1 = described, but not adequate) </p> </li> <li> <p>Was the study described as double‐blind? (1 = yes; 0 = no)</p> </li> <li> <p>Was the method of double‐blinding well described and adequate? (0 = not described; 1 = described and adequate; ‐1 = described, but not adequate) </p> </li> <li> <p>Was there a description of withdrawals and dropouts sufficient to determine the number of patients in each treatment group entering and completing the trial? (1 = yes; 0 = no) </p> </li> </ol> </p> <p>Each trial thus received a score of 0 to 5 points, with higher scores indicating higher quality in the conduct or reporting of the trial. Two review authors scored the studies independently, and a consensus score was then arrived at through discussion. The consensus score is reported for each study in the <a href="./references#CD010611-sec-0110" title="">Characteristics of included studies</a> table and was not used as a weighting in statistical analyses. </p> </section> <section id="CD010611-sec-0046"> <h4 class="title">Measures of treatment effect</h4> <p>The primary outcome considered for the efficacy analysis was headache frequency. Among headache frequency measures, we preferred number of migraine attacks to number of days with migraine. The latter measure confusingly incorporates attack duration into the measure of headache frequency. Moreover, attack duration is affected by the use of symptomatic medication, which is permitted in most trials. We also analysed headache frequency in terms of a responder rate, or the proportion of patients with a ≥ 50% reduction in headache frequency from pre‐ to post‐treatment. </p> <p>As noted above (<a href="#CD010611-sec-0044">Data extraction and management</a>), we kept patient‐reported quality of life data under review as studies were selected. There were no quality of life data available for rigorous analysis, but one study (<a href="./references#CD010611-bbs2-0001" title="AfshariD , RafizadehS , RezaeiM . A comparative study of the effects of low‐dose topiramate versus sodium valproate in migraine prophylaxis. International Journal of Neuroscience2012;122(2):60‐8. [MEDLINE: 21950578] ">Afshari 2012</a>) reported Migraine Disability Assessment (MIDAS) scores. </p> <p>The analysis considered only outcome data obtained directly from the patient and not those judged by the treating physician or study personnel. Efficacy data based on contemporaneous and timed (usually daily) recording of headache symptoms were preferred to those based on global or retrospective assessments. </p> <p>In addition, we tabulated adverse events for each included study.</p> </section> <section id="CD010611-sec-0047"> <h4 class="title">Unit of analysis issues</h4> <p>In the case of cross‐over trial designs, we anticipated that the data reported would normally not permit analysis of paired within‐patient data. We therefore analysed cross‐over trials as if they were parallel‐group trials, combining data from all treatment periods. If a carry‐over effect was found and data were reported by period, then the analysis was restricted to period‐one data only. In no trial were complete within‐patient data reported, so within‐patient improvement scores were not calculated. </p> </section> <section id="CD010611-sec-0048"> <h4 class="title">Dealing with missing data</h4> <p>Where data were missing or inadequate, we attempted to obtain these data by correspondence with study authors. </p> </section> <section id="CD010611-sec-0049"> <h4 class="title">Assessment of heterogeneity</h4> <p>We tested estimates of efficacy (both mean differences (MDs) and odds ratios (ORs)) for homogeneity. When significant heterogeneity was present, we made an attempt to explain the differences based on the clinical characteristics of the included studies. We did not statistically combine studies that were clinically dissimilar. However, when a group of studies with statistically heterogeneous results appeared to be clinically similar, we did combine study estimates. We performed all pooled analyses using a random‐effects model. </p> <p>As a sensitivity analysis, we also planned to calculate a pooled effect estimate using a fixed‐effect model for major outcomes (headache frequency, responder rate, and any AE) when the random‐effects result was near‐significant (0.05 ≤ P ≤ 0.15) and the pooled studies were homogeneous (heterogeneity statistics: P &gt; 0.15/I<sup>2</sup> &lt; 30%). Such a sensitivity analysis would evaluate whether conclusions might differ based on the statistical model used for pooling in situations where a fixed‐effect model might reasonably be considered instead of a random‐effects model. In fact, however, no such sensitivity analyses were warranted in the present review. </p> </section> <section id="CD010611-sec-0050"> <h4 class="title">Data synthesis</h4> <p>We anticipated that continuous outcome measures of headache frequency would be reported on different and often incompatible scales. Although we attempted to standardise the extraction of headache frequency data to a 28‐day (four‐week) period, this was not possible in every case. In our previous review (<a href="./references#CD010611-bbs2-0059" title="ChronicleEP , MullenersWM . Anticonvulsant drugs for migraine prophylaxis. Cochrane Database of Systematic Reviews2004, Issue 3. [DOI: 10.1002/14651858.CD003226.pub2] ">Chronicle 2004</a>; <a href="./references#CD010611-bbs2-0060" title="MullenersWM , ChronicleEP . Anticonvulsants in migraine prophylaxis: a Cochrane review. Cephalalgia2008;28(6):585‐97. [MEDLINE: 18454787] ">Mulleners 2008</a>), we therefore analysed these data using the standardised mean difference (SMD, with 95% confidence intervals (CIs)) rather than the mean difference (MD). The introduction of change scores in the newly included studies for some of the reviews in this series necessitated a change in the analysis plan from SMDs to MDs. The latter also has the advantage of giving a result in clinically meaningful units (ie, x fewer migraines per 28 days). </p> <p>We used dichotomous data meeting our definition of a clinically significant threshold to calculate odds ratios (ORs), with 95% CIs. Although we prefer ORs because of their statistical properties, some readers may find it simpler to interpret the clinical significance of our findings using risk ratios (RRs); we have therefore calculated RRs where appropriate. We additionally computed numbers needed to treat (NNTs), with 95% CIs, as the reciprocal of the risk difference (RD) versus placebo (<a href="./references#CD010611-bbs2-0048" title="McQuayH , MooreR . An Evidence‐based Resource for Pain Relief. Oxford: Oxford University Press, 1998. ">McQuay 1998</a>). </p> <p>In the same way, we used data on the proportion of patients reporting adverse events to calculate RDs and numbers needed to harm (NNHs). </p> </section> <section id="CD010611-sec-0051"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We undertook subgroup analyses by dose where possible. We considered further subgroup analyses by method of randomisation and by completeness of blinding, but did not undertake them because of insufficient data. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010611-sec-0052" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010611-sec-0052"></div> <section id="CD010611-sec-0053"> <h3 class="title">Description of studies</h3> <section id="CD010611-sec-0054"> <h4 class="title">Results of the search</h4> <p>The PubMed search strategy for our previous review (<a href="./references#CD010611-bbs2-0059" title="ChronicleEP , MullenersWM . Anticonvulsant drugs for migraine prophylaxis. Cochrane Database of Systematic Reviews2004, Issue 3. [DOI: 10.1002/14651858.CD003226.pub2] ">Chronicle 2004</a>; <a href="./references#CD010611-bbs2-0060" title="MullenersWM , ChronicleEP . Anticonvulsants in migraine prophylaxis: a Cochrane review. Cephalalgia2008;28(6):585‐97. [MEDLINE: 18454787] ">Mulleners 2008</a>) yielded 1089 potentially eligible citations, while the EMBASE and CENTRAL searches yielded 290 and 6952 citations, respectively. No additional citations were retrieved from the Cochrane Pain, Palliative &amp; Supportive Care Trials Register or from other sources. After title and abstract screening, we obtained 58 published papers on antiepileptics for full‐text scrutiny. Of these, 22 (nine included, 13 excluded) investigated valproate. </p> <p>The MEDLINE search strategy for the present update (from 2005 on) yielded 188 citations as possible candidates for the current series of reviews on antiepileptic drugs for migraine prophylaxis; the search of MEDLINE In‐Process identified an additional 20 citations. The EMBASE and CENTRAL updates identified 484 and 85 citations, respectively. Three additional study reports (all unpublished and all pertaining to gabapentin) were identified from other sources. After title and abstract screening, we obtained 37 published and three unpublished papers on antiepileptics for full‐text scrutiny. Of these, seven (one included, six excluded) investigated valproate. </p> <p>Thus, for the present update, we reviewed a total of 29 papers on valproate at the full‐text screening stage. Of these, we included 10 papers and excluded 19. </p> </section> <section id="CD010611-sec-0055"> <h4 class="title">Included studies</h4> <p>The 10 included papers reported data from 10 unique studies, including four trials of divalproex sodium (<a href="./references#CD010611-bbs2-0002" title="FreitagFG , CollinsSD , CarlsonHA , GoldsteinJ , SaperJ , SilbersteinS , et al. A randomized trial of divalproex sodium extended‐release tablets in migraine prophylaxis. Neurology2002;58(11):1652‐9. [MEDLINE: 12058094] ">Freitag 2002</a>; <a href="./references#CD010611-bbs2-0005" title="KanieckiRG . A comparison of divalproex with propanolol and placebo for the prophylaxis of migraine without aura. Archives of Neurology1997;54(9):1141‐5. [MEDLINE: 9311358] ">Kaniecki 1997</a>; <a href="./references#CD010611-bbs2-0007" title="KlapperJ , on behalf of the Divalproex Sodium in Migraine Prophylaxis Study Group. Divalproex sodium in migraine prophylaxis: a dose‐controlled study. Cephalalgia1997;17(2):103‐8. [MEDLINE: 9137847] ">Klapper 1997</a>; <a href="./references#CD010611-bbs2-0008" title="MathewNT , SaperJR , SilbersteinSD , RankinL , MarkleyHG , SolomonS , et al. Migraine prophylaxis with divalproex. Archives of Neurology1995;52(3):281‐6. [MEDLINE: 7872882] ">Mathew 1995</a>) and six trials of sodium valproate (<a href="./references#CD010611-bbs2-0001" title="AfshariD , RafizadehS , RezaeiM . A comparative study of the effects of low‐dose topiramate versus sodium valproate in migraine prophylaxis. International Journal of Neuroscience2012;122(2):60‐8. [MEDLINE: 21950578] ">Afshari 2012</a>; <a href="./references#CD010611-bbs2-0003" title="HeringR , KuritzkyA . Sodium valproate in the prophylactic treatment of migraine: a double‐blind study versus placebo. Cephalalgia1992;12(2):81‐4. [MEDLINE: 1576648] ">Hering 1992</a>; <a href="./references#CD010611-bbs2-0004" title="JensenR , BrinckT , OlesenJ . Sodium valproate has a prophylactic effect in migraine without aura: a triple‐blind, placebo‐controlled crossover study. Neurology1994;44(4):647‐51. [MEDLINE: 8164818] ">Jensen 1994</a>; <a href="./references#CD010611-bbs2-0006" title="KinzeS , ClaussM , ReuterU , WolfT , DreierJP , EinhauplKM , et al. Valproic acid is effective in migraine prophylaxis at low serum levels: a prospective open‐label study. Headache2001;41(8):774‐8. [MEDLINE: 11576201] ">Kinze 2001</a>; <a href="./references#CD010611-bbs2-0009" title="MitsikostasDD , PolychronidisI . Valproate versus flunarizine in migraine prophylaxis: a randomized, double‐open, clinical trial. Functional Neurology1997;12(5):267‐76. [MEDLINE: 9439944] ">Mitsikostas 1997</a>; <a href="./references#CD010611-bbs2-0010" title="ShaygannejadV , JanghorbaniM , GhorbaniA , AshtaryF , ZakizadeN , NasrV . Comparison of the effect of topiramate and sodium valproate in migraine prevention: a randomized blinded crossover study. Headache2006;46(4):642‐8. [MEDLINE: 16643559] ">Shaygannejad 2006</a>). Six trials compared valproate with placebo (<a href="./references#CD010611-bbs2-0002" title="FreitagFG , CollinsSD , CarlsonHA , GoldsteinJ , SaperJ , SilbersteinS , et al. A randomized trial of divalproex sodium extended‐release tablets in migraine prophylaxis. Neurology2002;58(11):1652‐9. [MEDLINE: 12058094] ">Freitag 2002</a>; <a href="./references#CD010611-bbs2-0003" title="HeringR , KuritzkyA . Sodium valproate in the prophylactic treatment of migraine: a double‐blind study versus placebo. Cephalalgia1992;12(2):81‐4. [MEDLINE: 1576648] ">Hering 1992</a>; <a href="./references#CD010611-bbs2-0004" title="JensenR , BrinckT , OlesenJ . Sodium valproate has a prophylactic effect in migraine without aura: a triple‐blind, placebo‐controlled crossover study. Neurology1994;44(4):647‐51. [MEDLINE: 8164818] ">Jensen 1994</a>; <a href="./references#CD010611-bbs2-0005" title="KanieckiRG . A comparison of divalproex with propanolol and placebo for the prophylaxis of migraine without aura. Archives of Neurology1997;54(9):1141‐5. [MEDLINE: 9311358] ">Kaniecki 1997</a>; <a href="./references#CD010611-bbs2-0007" title="KlapperJ , on behalf of the Divalproex Sodium in Migraine Prophylaxis Study Group. Divalproex sodium in migraine prophylaxis: a dose‐controlled study. Cephalalgia1997;17(2):103‐8. [MEDLINE: 9137847] ">Klapper 1997</a>; <a href="./references#CD010611-bbs2-0008" title="MathewNT , SaperJR , SilbersteinSD , RankinL , MarkleyHG , SolomonS , et al. Migraine prophylaxis with divalproex. Archives of Neurology1995;52(3):281‐6. [MEDLINE: 7872882] ">Mathew 1995</a>), four compared valproate to active intervention (<a href="./references#CD010611-bbs2-0001" title="AfshariD , RafizadehS , RezaeiM . A comparative study of the effects of low‐dose topiramate versus sodium valproate in migraine prophylaxis. International Journal of Neuroscience2012;122(2):60‐8. [MEDLINE: 21950578] ">Afshari 2012</a>; <a href="./references#CD010611-bbs2-0005" title="KanieckiRG . A comparison of divalproex with propanolol and placebo for the prophylaxis of migraine without aura. Archives of Neurology1997;54(9):1141‐5. [MEDLINE: 9311358] ">Kaniecki 1997</a>; <a href="./references#CD010611-bbs2-0009" title="MitsikostasDD , PolychronidisI . Valproate versus flunarizine in migraine prophylaxis: a randomized, double‐open, clinical trial. Functional Neurology1997;12(5):267‐76. [MEDLINE: 9439944] ">Mitsikostas 1997</a>; <a href="./references#CD010611-bbs2-0010" title="ShaygannejadV , JanghorbaniM , GhorbaniA , AshtaryF , ZakizadeN , NasrV . Comparison of the effect of topiramate and sodium valproate in migraine prevention: a randomized blinded crossover study. Headache2006;46(4):642‐8. [MEDLINE: 16643559] ">Shaygannejad 2006</a>), and one reported data that enabled dose comparisons of valproate (<a href="./references#CD010611-bbs2-0006" title="KinzeS , ClaussM , ReuterU , WolfT , DreierJP , EinhauplKM , et al. Valproic acid is effective in migraine prophylaxis at low serum levels: a prospective open‐label study. Headache2001;41(8):774‐8. [MEDLINE: 11576201] ">Kinze 2001</a>). </p> <p>Four trials (<a href="./references#CD010611-bbs2-0003" title="HeringR , KuritzkyA . Sodium valproate in the prophylactic treatment of migraine: a double‐blind study versus placebo. Cephalalgia1992;12(2):81‐4. [MEDLINE: 1576648] ">Hering 1992</a>; <a href="./references#CD010611-bbs2-0004" title="JensenR , BrinckT , OlesenJ . Sodium valproate has a prophylactic effect in migraine without aura: a triple‐blind, placebo‐controlled crossover study. Neurology1994;44(4):647‐51. [MEDLINE: 8164818] ">Jensen 1994</a>; <a href="./references#CD010611-bbs2-0005" title="KanieckiRG . A comparison of divalproex with propanolol and placebo for the prophylaxis of migraine without aura. Archives of Neurology1997;54(9):1141‐5. [MEDLINE: 9311358] ">Kaniecki 1997</a>; <a href="./references#CD010611-bbs2-0010" title="ShaygannejadV , JanghorbaniM , GhorbaniA , AshtaryF , ZakizadeN , NasrV . Comparison of the effect of topiramate and sodium valproate in migraine prevention: a randomized blinded crossover study. Headache2006;46(4):642‐8. [MEDLINE: 16643559] ">Shaygannejad 2006</a>) had a cross‐over design, whereas the other six trials had a parallel‐group design (<a href="./references#CD010611-bbs2-0001" title="AfshariD , RafizadehS , RezaeiM . A comparative study of the effects of low‐dose topiramate versus sodium valproate in migraine prophylaxis. International Journal of Neuroscience2012;122(2):60‐8. [MEDLINE: 21950578] ">Afshari 2012</a>; <a href="./references#CD010611-bbs2-0002" title="FreitagFG , CollinsSD , CarlsonHA , GoldsteinJ , SaperJ , SilbersteinS , et al. A randomized trial of divalproex sodium extended‐release tablets in migraine prophylaxis. Neurology2002;58(11):1652‐9. [MEDLINE: 12058094] ">Freitag 2002</a>; <a href="./references#CD010611-bbs2-0006" title="KinzeS , ClaussM , ReuterU , WolfT , DreierJP , EinhauplKM , et al. Valproic acid is effective in migraine prophylaxis at low serum levels: a prospective open‐label study. Headache2001;41(8):774‐8. [MEDLINE: 11576201] ">Kinze 2001</a>; <a href="./references#CD010611-bbs2-0007" title="KlapperJ , on behalf of the Divalproex Sodium in Migraine Prophylaxis Study Group. Divalproex sodium in migraine prophylaxis: a dose‐controlled study. Cephalalgia1997;17(2):103‐8. [MEDLINE: 9137847] ">Klapper 1997</a>; <a href="./references#CD010611-bbs2-0008" title="MathewNT , SaperJR , SilbersteinSD , RankinL , MarkleyHG , SolomonS , et al. Migraine prophylaxis with divalproex. Archives of Neurology1995;52(3):281‐6. [MEDLINE: 7872882] ">Mathew 1995</a>; <a href="./references#CD010611-bbs2-0009" title="MitsikostasDD , PolychronidisI . Valproate versus flunarizine in migraine prophylaxis: a randomized, double‐open, clinical trial. Functional Neurology1997;12(5):267‐76. [MEDLINE: 9439944] ">Mitsikostas 1997</a>). </p> <p>The doses of valproate investigated in the 10 included trials ranged from 400 to 1500 mg/day. This can be compared to the range of doses used in epilepsy, which is 750 to 4000 mg/day. </p> <p>The duration of the treatment phase of the included trials varied from eight to 12 weeks, with a mean of 11 weeks. </p> <p>See the <a href="./references#CD010611-sec-0110" title="">Characteristics of included studies</a> for further details. </p> </section> <section id="CD010611-sec-0056"> <h4 class="title">Excluded studies</h4> <p>Of the 29 papers obtained for full‐text scrutiny, 19 were excluded for reasons given in the <a href="./references#CD010611-sec-0111" title="">Characteristics of excluded studies</a> table. The most common reasons for exclusion were: no control group (five papers), comparator an experimental intervention (three papers), and review article (two papers). </p> </section> </section> <section id="CD010611-sec-0057"> <h3 class="title">Risk of bias in included studies</h3> <p>We scored methodological quality using the Jadad scale as indicated in the <a href="#CD010611-sec-0045">Assessment of risk of bias in included studies</a> section, with a maximum attainable score of 5. The median quality score was 3.5 (mean 3.2; range 1 to 5). </p> <p>Of 60 risk of bias items scored for the 10 studies, the majority of ratings were either 'unclear' (23 (38%)) or 'low' (20 (33%)) (<a href="#CD010611-fig-0001">Figure 1</a>; <a href="#CD010611-fig-0002">Figure 2</a>); we judged seven studies (<a href="./references#CD010611-bbs2-0001" title="AfshariD , RafizadehS , RezaeiM . A comparative study of the effects of low‐dose topiramate versus sodium valproate in migraine prophylaxis. International Journal of Neuroscience2012;122(2):60‐8. [MEDLINE: 21950578] ">Afshari 2012</a>; <a href="./references#CD010611-bbs2-0003" title="HeringR , KuritzkyA . Sodium valproate in the prophylactic treatment of migraine: a double‐blind study versus placebo. Cephalalgia1992;12(2):81‐4. [MEDLINE: 1576648] ">Hering 1992</a>; <a href="./references#CD010611-bbs2-0004" title="JensenR , BrinckT , OlesenJ . Sodium valproate has a prophylactic effect in migraine without aura: a triple‐blind, placebo‐controlled crossover study. Neurology1994;44(4):647‐51. [MEDLINE: 8164818] ">Jensen 1994</a>; <a href="./references#CD010611-bbs2-0005" title="KanieckiRG . A comparison of divalproex with propanolol and placebo for the prophylaxis of migraine without aura. Archives of Neurology1997;54(9):1141‐5. [MEDLINE: 9311358] ">Kaniecki 1997</a>; <a href="./references#CD010611-bbs2-0006" title="KinzeS , ClaussM , ReuterU , WolfT , DreierJP , EinhauplKM , et al. Valproic acid is effective in migraine prophylaxis at low serum levels: a prospective open‐label study. Headache2001;41(8):774‐8. [MEDLINE: 11576201] ">Kinze 2001</a>; <a href="./references#CD010611-bbs2-0007" title="KlapperJ , on behalf of the Divalproex Sodium in Migraine Prophylaxis Study Group. Divalproex sodium in migraine prophylaxis: a dose‐controlled study. Cephalalgia1997;17(2):103‐8. [MEDLINE: 9137847] ">Klapper 1997</a>; <a href="./references#CD010611-bbs2-0009" title="MitsikostasDD , PolychronidisI . Valproate versus flunarizine in migraine prophylaxis: a randomized, double‐open, clinical trial. Functional Neurology1997;12(5):267‐76. [MEDLINE: 9439944] ">Mitsikostas 1997</a>) as having a 'high' risk of bias for at least one item (<a href="#CD010611-fig-0002">Figure 2</a>). One of these studies (<a href="./references#CD010611-bbs2-0006" title="KinzeS , ClaussM , ReuterU , WolfT , DreierJP , EinhauplKM , et al. Valproic acid is effective in migraine prophylaxis at low serum levels: a prospective open‐label study. Headache2001;41(8):774‐8. [MEDLINE: 11576201] ">Kinze 2001</a>) was judged as having a high risk of bias for all six items assessed. </p> <div class="figure" id="CD010611-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010611-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_n/nCD010611-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD010611-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010611-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_n/nCD010611-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD010611-sec-0058"> <h4 class="title">Allocation</h4> <p>Only two studies (<a href="./references#CD010611-bbs2-0001" title="AfshariD , RafizadehS , RezaeiM . A comparative study of the effects of low‐dose topiramate versus sodium valproate in migraine prophylaxis. International Journal of Neuroscience2012;122(2):60‐8. [MEDLINE: 21950578] ">Afshari 2012</a>; <a href="./references#CD010611-bbs2-0002" title="FreitagFG , CollinsSD , CarlsonHA , GoldsteinJ , SaperJ , SilbersteinS , et al. A randomized trial of divalproex sodium extended‐release tablets in migraine prophylaxis. Neurology2002;58(11):1652‐9. [MEDLINE: 12058094] ">Freitag 2002</a>) provided an adequate methodological description (computer‐generated randomisation schedule) of how allocation sequences were generated (see the <a href="./references#CD010611-sec-0110" title="">Characteristics of included studies</a> table). Likewise, only <a href="./references#CD010611-bbs2-0001" title="AfshariD , RafizadehS , RezaeiM . A comparative study of the effects of low‐dose topiramate versus sodium valproate in migraine prophylaxis. International Journal of Neuroscience2012;122(2):60‐8. [MEDLINE: 21950578] ">Afshari 2012</a> and <a href="./references#CD010611-bbs2-0002" title="FreitagFG , CollinsSD , CarlsonHA , GoldsteinJ , SaperJ , SilbersteinS , et al. A randomized trial of divalproex sodium extended‐release tablets in migraine prophylaxis. Neurology2002;58(11):1652‐9. [MEDLINE: 12058094] ">Freitag 2002</a> provided an adequate methodological description (preprinted medication code labels and sealed envelopes) of attempts to conceal allocation of intervention assignment (see the <a href="./references#CD010611-sec-0110" title="">Characteristics of included studies</a> table). A high risk of selection bias was valued for <a href="./references#CD010611-bbs2-0006" title="KinzeS , ClaussM , ReuterU , WolfT , DreierJP , EinhauplKM , et al. Valproic acid is effective in migraine prophylaxis at low serum levels: a prospective open‐label study. Headache2001;41(8):774‐8. [MEDLINE: 11576201] ">Kinze 2001</a> and <a href="./references#CD010611-bbs2-0009" title="MitsikostasDD , PolychronidisI . Valproate versus flunarizine in migraine prophylaxis: a randomized, double‐open, clinical trial. Functional Neurology1997;12(5):267‐76. [MEDLINE: 9439944] ">Mitsikostas 1997</a> due to their open‐label design in combination with a lack of description of predefined randomisation schedules. </p> </section> <section id="CD010611-sec-0059"> <h4 class="title">Blinding</h4> <p>Both participants and clinicians were blinded during the conduct of the majority of studies (7/10), and adequate methodological descriptions are reported for five of them (see <a href="#CD010611-fig-0002">Figure 2</a> and <a href="./references#CD010611-sec-0110" title="">Characteristics of included studies</a> table). Double‐blinding was typically achieved by packaging and labelling identical appearing tablets according to the randomisation codes. In <a href="./references#CD010611-bbs2-0001" title="AfshariD , RafizadehS , RezaeiM . A comparative study of the effects of low‐dose topiramate versus sodium valproate in migraine prophylaxis. International Journal of Neuroscience2012;122(2):60‐8. [MEDLINE: 21950578] ">Afshari 2012</a>, there is no mention of identical appearing tablets, and it is thus possible that standard medication was provided by third party according to allocation label. We therefore judged this study as suffering from a high risk of performance bias. In <a href="./references#CD010611-bbs2-0005" title="KanieckiRG . A comparison of divalproex with propanolol and placebo for the prophylaxis of migraine without aura. Archives of Neurology1997;54(9):1141‐5. [MEDLINE: 9311358] ">Kaniecki 1997</a>, even the stated single‐blinding is questionable, since divalproex, propranolol, and placebo had different appearances. <a href="./references#CD010611-bbs2-0006" title="KinzeS , ClaussM , ReuterU , WolfT , DreierJP , EinhauplKM , et al. Valproic acid is effective in migraine prophylaxis at low serum levels: a prospective open‐label study. Headache2001;41(8):774‐8. [MEDLINE: 11576201] ">Kinze 2001</a> and <a href="./references#CD010611-bbs2-0009" title="MitsikostasDD , PolychronidisI . Valproate versus flunarizine in migraine prophylaxis: a randomized, double‐open, clinical trial. Functional Neurology1997;12(5):267‐76. [MEDLINE: 9439944] ">Mitsikostas 1997</a> were open‐label studies and therefore also had a high risk of performance bias. In <a href="./references#CD010611-bbs2-0005" title="KanieckiRG . A comparison of divalproex with propanolol and placebo for the prophylaxis of migraine without aura. Archives of Neurology1997;54(9):1141‐5. [MEDLINE: 9311358] ">Kaniecki 1997</a>, the single investigator was not blinded until he reviewed the diaries for outcomes assessment. Since the sample of this study was small, and non‐completers were excluded from the analysis, he could possibly have recognised some of the participants and the interventions they were using. Remarkably, no paper clearly stated that the analyst was effectively blinded. The risk of detection bias in all studies is therefore unclear. </p> </section> <section id="CD010611-sec-0060"> <h4 class="title">Incomplete outcome data</h4> <p>Only in four of the 10 studies was completeness of data adequately reported (<a href="#CD010611-fig-0002">Figure 2</a>). Usually in these papers an intention‐to‐treat (ITT) analysis was applied (see the <a href="./references#CD010611-sec-0110" title="">Characteristics of included studies</a> table). We were particularly concerned about incomplete outcome data in <a href="./references#CD010611-bbs2-0004" title="JensenR , BrinckT , OlesenJ . Sodium valproate has a prophylactic effect in migraine without aura: a triple‐blind, placebo‐controlled crossover study. Neurology1994;44(4):647‐51. [MEDLINE: 8164818] ">Jensen 1994</a>, <a href="./references#CD010611-bbs2-0005" title="KanieckiRG . A comparison of divalproex with propanolol and placebo for the prophylaxis of migraine without aura. Archives of Neurology1997;54(9):1141‐5. [MEDLINE: 9311358] ">Kaniecki 1997</a>, <a href="./references#CD010611-bbs2-0006" title="KinzeS , ClaussM , ReuterU , WolfT , DreierJP , EinhauplKM , et al. Valproic acid is effective in migraine prophylaxis at low serum levels: a prospective open‐label study. Headache2001;41(8):774‐8. [MEDLINE: 11576201] ">Kinze 2001</a>, and <a href="./references#CD010611-bbs2-0009" title="MitsikostasDD , PolychronidisI . Valproate versus flunarizine in migraine prophylaxis: a randomized, double‐open, clinical trial. Functional Neurology1997;12(5):267‐76. [MEDLINE: 9439944] ">Mitsikostas 1997</a>, which considered complete cases only, excluding the other participants from analysis. In addition, <a href="./references#CD010611-bbs2-0003" title="HeringR , KuritzkyA . Sodium valproate in the prophylactic treatment of migraine: a double‐blind study versus placebo. Cephalalgia1992;12(2):81‐4. [MEDLINE: 1576648] ">Hering 1992</a> does not report the size of the safety evaluable sample. </p> </section> <section id="CD010611-sec-0061"> <h4 class="title">Selective reporting</h4> <p>We judged the risk of reporting bias as low in six of the 10 studies (<a href="#CD010611-fig-0002">Figure 2</a>). Selective availability of data was encountered in <a href="./references#CD010611-bbs2-0005" title="KanieckiRG . A comparison of divalproex with propanolol and placebo for the prophylaxis of migraine without aura. Archives of Neurology1997;54(9):1141‐5. [MEDLINE: 9311358] ">Kaniecki 1997</a> (nocebo effect not reported, precluding calculation of NNHs), <a href="./references#CD010611-bbs2-0006" title="KinzeS , ClaussM , ReuterU , WolfT , DreierJP , EinhauplKM , et al. Valproic acid is effective in migraine prophylaxis at low serum levels: a prospective open‐label study. Headache2001;41(8):774‐8. [MEDLINE: 11576201] ">Kinze 2001</a> (inadequate reporting of adverse events), and <a href="./references#CD010611-bbs2-0007" title="KlapperJ , on behalf of the Divalproex Sodium in Migraine Prophylaxis Study Group. Divalproex sodium in migraine prophylaxis: a dose‐controlled study. Cephalalgia1997;17(2):103‐8. [MEDLINE: 9137847] ">Klapper 1997</a> (dose comparisons not possible, as insufficient data were provided). </p> </section> <section id="CD010611-sec-0062"> <h4 class="title">Other potential sources of bias</h4> <p>Statistically significant results are more likely to be published than trials affirming a null result. This tendency for negative or inconclusive results to remain unpublished is inherently problematic also in the context of this review. </p> </section> </section> <section id="CD010611-sec-0063"> <h3 class="title" id="CD010611-sec-0063">Effects of interventions</h3> <section id="CD010611-sec-0064"> <h4 class="title">Methodological considerations</h4> <p>Significant statistical heterogeneity was evident across trials for both efficacy outcomes. The clinical similarity of trials was therefore examined to determine whether studies should be combined for statistical meta‐analysis. Although there was methodological variation as described above (<a href="#CD010611-sec-0057">Risk of bias in included studies</a>), the included trials were fundamentally similar with regard to basic design, patients, and measures. </p> <p>All doses reported below are given in terms of mg/day.</p> </section> <section id="CD010611-sec-0065"> <h4 class="title">Valproate versus placebo</h4> <section id="CD010611-sec-0066"> <h5 class="title">Divalproex sodium</h5> <p>None of the four trials comparing divalproex sodium with placebo (<a href="./references#CD010611-bbs2-0002" title="FreitagFG , CollinsSD , CarlsonHA , GoldsteinJ , SaperJ , SilbersteinS , et al. A randomized trial of divalproex sodium extended‐release tablets in migraine prophylaxis. Neurology2002;58(11):1652‐9. [MEDLINE: 12058094] ">Freitag 2002</a>; <a href="./references#CD010611-bbs2-0005" title="KanieckiRG . A comparison of divalproex with propanolol and placebo for the prophylaxis of migraine without aura. Archives of Neurology1997;54(9):1141‐5. [MEDLINE: 9311358] ">Kaniecki 1997</a>; <a href="./references#CD010611-bbs2-0007" title="KlapperJ , on behalf of the Divalproex Sodium in Migraine Prophylaxis Study Group. Divalproex sodium in migraine prophylaxis: a dose‐controlled study. Cephalalgia1997;17(2):103‐8. [MEDLINE: 9137847] ">Klapper 1997</a>; <a href="./references#CD010611-bbs2-0008" title="MathewNT , SaperJR , SilbersteinSD , RankinL , MarkleyHG , SolomonS , et al. Migraine prophylaxis with divalproex. Archives of Neurology1995;52(3):281‐6. [MEDLINE: 7872882] ">Mathew 1995</a>) reported sufficient data for us to calculate mean differences (MDs) for headache frequency, our preferred outcome measure. </p> <p>All four trials did, however, report data on responders. Analysis of these data showed, overall, that active treatment was significantly superior to placebo for this outcome (odds ratio (OR) 3.34; 95% confidence interval (CI) 1.46 to 7.67; 542 patients (one cross‐over study had 32 patients); <a href="./references#CD010611-fig-0003" title="">Analysis 1.1</a>). In clinical terms, the observed effect suggests that patients are approximately twice as likely to experience a ≥ 50% reduction in headache frequency with divalproex sodium as with placebo. Details are as follows: </p> <p> <ul id="CD010611-list-0004"> <li> <p>The proportion of responders with divalproex sodium was 42% (147/349; range: 30% to 66%); </p> </li> <li> <p>The proportion of responders with placebo was 21% (48/225; range 14% to 24%);</p> </li> <li> <p>The risk ratio (RR) for divalproex sodium versus placebo was 2.18 (95% CI 1.28 to 3.72; <a href="./references#CD010611-fig-0004" title="">Analysis 1.2</a>); </p> </li> <li> <p>The number needed to treat (NNT) for divalproex sodium versus placebo was 4 (95% CI 2 to 11). </p> </li> </ul> </p> <p>It is notable that the largest of the four studies analysed (<a href="./references#CD010611-bbs2-0002" title="FreitagFG , CollinsSD , CarlsonHA , GoldsteinJ , SaperJ , SilbersteinS , et al. A randomized trial of divalproex sodium extended‐release tablets in migraine prophylaxis. Neurology2002;58(11):1652‐9. [MEDLINE: 12058094] ">Freitag 2002</a>; 234 patients) found no significant difference between active treatment and placebo. </p> </section> <section id="CD010611-sec-0067"> <h5 class="title">Sodium valproate</h5> <p>Two cross‐over trials of sodium valproate (<a href="./references#CD010611-bbs2-0003" title="HeringR , KuritzkyA . Sodium valproate in the prophylactic treatment of migraine: a double‐blind study versus placebo. Cephalalgia1992;12(2):81‐4. [MEDLINE: 1576648] ">Hering 1992</a>; <a href="./references#CD010611-bbs2-0004" title="JensenR , BrinckT , OlesenJ . Sodium valproate has a prophylactic effect in migraine without aura: a triple‐blind, placebo‐controlled crossover study. Neurology1994;44(4):647‐51. [MEDLINE: 8164818] ">Jensen 1994</a>; 63 patients) showed a significant reduction in headache frequency (per 28‐day period) in the active group compared to the placebo group (MD ‐4.31; 95% CI ‐8.32 to ‐0.30; <a href="./references#CD010611-fig-0005" title="">Analysis 2.1</a>). In clinical terms, the observed effect corresponds to a reduction in headache frequency of approximately four headaches per 28 days. The mean baseline headache frequency in the valproate group (reported only by <a href="./references#CD010611-bbs2-0004" title="JensenR , BrinckT , OlesenJ . Sodium valproate has a prophylactic effect in migraine without aura: a triple‐blind, placebo‐controlled crossover study. Neurology1994;44(4):647‐51. [MEDLINE: 8164818] ">Jensen 1994</a>, and only for completers) was 6.1 headaches per 28 days. </p> <p>One cross‐over trial (<a href="./references#CD010611-bbs2-0004" title="JensenR , BrinckT , OlesenJ . Sodium valproate has a prophylactic effect in migraine without aura: a triple‐blind, placebo‐controlled crossover study. Neurology1994;44(4):647‐51. [MEDLINE: 8164818] ">Jensen 1994</a>; 34 patients) reported data on responders; these showed that sodium valproate was significantly superior to placebo for this outcome (OR 4.67; 95% CI 1.54 to 14.14; <a href="./references#CD010611-fig-0006" title="">Analysis 2.2</a>). In clinical terms, the observed effect suggests that patients are nearly three times as likely to experience a ≥ 50% reduction in headache frequency with sodium valproate as with placebo. Details are as follows: </p> <p> <ul id="CD010611-list-0005"> <li> <p>The proportion of responders with sodium valproate was 50% (17/34);</p> </li> <li> <p>The proportion of responders with placebo was 18% (6/34);</p> </li> <li> <p>The RR for sodium valproate versus placebo was 2.83 (95% CI 1.27 to 6.31; <a href="./references#CD010611-fig-0007" title="">Analysis 2.3</a>); </p> </li> <li> <p>The NNT for sodium valproate versus placebo was 3 (95% CI 2 to 9).</p> </li> </ul> </p> </section> </section> <section id="CD010611-sec-0068"> <h4 class="title">Dose comparisons for sodium valproate</h4> <p>One parallel‐group trial (<a href="./references#CD010611-bbs2-0006" title="KinzeS , ClaussM , ReuterU , WolfT , DreierJP , EinhauplKM , et al. Valproic acid is effective in migraine prophylaxis at low serum levels: a prospective open‐label study. Headache2001;41(8):774‐8. [MEDLINE: 11576201] ">Kinze 2001</a>) compared different doses of sodium valproate by measuring serum valproate concentrations. The study showed that lower (21 to 50 µg/ml) serum levels gave rise to slightly but significantly lower headache frequency than higher (&gt; 50 µg/ml) serum levels (MD 0.80; 95% CI 0.24 to 1.36; 45 patients; <a href="./references#CD010611-fig-0008" title="">Analysis 3.1</a>). In clinical terms, the observed effect corresponds to a reduction in headache frequency of approximately one headache per 28 days in the lower versus the higher serum level group. The mean baseline headache frequency (reported only for the study population as a whole) was 3.5 headaches per 28 days. </p> </section> <section id="CD010611-sec-0069"> <h4 class="title">Sodium valproate versus flunarizine</h4> <p>One parallel‐group trial (<a href="./references#CD010611-bbs2-0009" title="MitsikostasDD , PolychronidisI . Valproate versus flunarizine in migraine prophylaxis: a randomized, double‐open, clinical trial. Functional Neurology1997;12(5):267‐76. [MEDLINE: 9439944] ">Mitsikostas 1997</a>) compared sodium valproate with flunarizine. Data were insufficient for us to calculate MDs for headache frequency, our preferred outcome measure. There was no significant difference between sodium valproate and flunarizine in the proportion of responders (OR 1.07; 95% CI 0.28 to 4.12; 41 patients; <a href="./references#CD010611-fig-0009" title="">Analysis 4.1</a>). </p> </section> <section id="CD010611-sec-0070"> <h4 class="title">Divalproex sodium versus propranolol</h4> <p>A further (cross‐over) trial using an active comparator examined divalproex sodium versus propranolol (<a href="./references#CD010611-bbs2-0005" title="KanieckiRG . A comparison of divalproex with propanolol and placebo for the prophylaxis of migraine without aura. Archives of Neurology1997;54(9):1141‐5. [MEDLINE: 9311358] ">Kaniecki 1997</a>). Data were insufficient for us to calculate MDs for headache frequency, our preferred outcome measure. There was no significant difference between treatments in the proportion of responders (OR 1.15; 95% CI 0.41 to 3.18; 32 patients; <a href="./references#CD010611-fig-0010" title="">Analysis 5.1</a>). </p> </section> <section id="CD010611-sec-0071"> <h4 class="title">Sodium valproate versus topiramate</h4> <p>Two fairly small studies compared topiramate 50 mg with sodium valproate 400 mg. <a href="./references#CD010611-bbs2-0001" title="AfshariD , RafizadehS , RezaeiM . A comparative study of the effects of low‐dose topiramate versus sodium valproate in migraine prophylaxis. International Journal of Neuroscience2012;122(2):60‐8. [MEDLINE: 21950578] ">Afshari 2012</a> did not demonstrate a significant difference in mean headache frequency during treatment (MD ‐0.60; 95% CI ‐1.57 to 0.37; 56 participants; <a href="./references#CD010611-fig-0011" title="">Analysis 6.1</a>). On the basis of their statistical analysis, the authors of <a href="./references#CD010611-bbs2-0010" title="ShaygannejadV , JanghorbaniM , GhorbaniA , AshtaryF , ZakizadeN , NasrV . Comparison of the effect of topiramate and sodium valproate in migraine prevention: a randomized blinded crossover study. Headache2006;46(4):642‐8. [MEDLINE: 16643559] ">Shaygannejad 2006</a> found no significant differences in efficacy between the two drugs. However, our analysis of post‐treatment mean headache frequencies demonstrated a slight but significant advantage for topiramate over valproate (MD ‐1.20; 95% CI ‐2.16 to ‐0.24; 32 (cross‐over) participants; <a href="./references#CD010611-fig-0011" title="">Analysis 6.1</a>). The pooled results of these two studies indicate a significant difference between topiramate and sodium valproate, in favour of topiramate, for this outcome (MD ‐0.90; 95% CI ‐1.58 to ‐0.22; <a href="./references#CD010611-fig-0011" title="">Analysis 6.1</a>). In clinical terms, the observed effect corresponds to a reduction in headache frequency of approximately one headache per 28 days with topiramate versus sodium valproate. The median baseline headache frequency in the topiramate groups of the two trials was 6.1 headaches per 28 days (mean 6.1; range: 5.4 to 6.8). It should be noted that the doses used in these two studies are not those used in routine clinical practice for the management of migraine. </p> <p><a href="./references#CD010611-bbs2-0001" title="AfshariD , RafizadehS , RezaeiM . A comparative study of the effects of low‐dose topiramate versus sodium valproate in migraine prophylaxis. International Journal of Neuroscience2012;122(2):60‐8. [MEDLINE: 21950578] ">Afshari 2012</a> was the only study to report data on migraine‐related disability. These data showed no significant difference in Migraine Disability Assessment (MIDAS) scores between sodium valproate and topiramate (MD ‐3.90; 95% CI ‐8.72 to 0.92; 56 participants; <a href="./references#CD010611-fig-0012" title="">Analysis 6.2</a>). </p> </section> <section id="CD010611-sec-0072"> <h4 class="title">Safety</h4> <p>During the process of extracting safety data, it became clear that the range of adverse events and the method of their reporting varied very considerably from trial to trial. Because of the fundamental similarity of sodium valproate and divalproex sodium, safety data from trials of these drugs against placebo were analysed together. We calculated risk differences (RDs) for any adverse event (<a href="./references#CD010611-fig-0013" title="">Analysis 7.1</a>), and for the five specific adverse events we judged to be of greatest clinical importance, namely, asthenia/fatigue (<a href="./references#CD010611-fig-0014" title="">Analysis 7.2</a>), dizziness/vertigo (<a href="./references#CD010611-fig-0015" title="">Analysis 7.3</a>), nausea (<a href="./references#CD010611-fig-0016" title="">Analysis 7.4</a>), tremor (<a href="./references#CD010611-fig-0017" title="">Analysis 7.5</a>), and weight gain (<a href="./references#CD010611-fig-0018" title="">Analysis 7.6</a>). Numbers needed to harm (NNHs) (with 95% CIs) were as follows: </p> <p> <ul id="CD010611-list-0006"> <li> <p>Any adverse event: NNH not calculated, since 95% CI for RD includes zero.</p> </li> <li> <p>Asthenia/fatigue: NNH not calculated, since 95% CI for RD includes zero.</p> </li> <li> <p>Dizziness/vertigo: NNH 14 (8 to 100).</p> </li> <li> <p>Nausea: NNH 7 (4 to 25).</p> </li> <li> <p>Tremor: NNH 14 (8 to 100).</p> </li> <li> <p>Weight gain: NNH not calculated, since 95% CI for RD includes zero.</p> </li> </ul> </p> <p>Five of the six placebo‐controlled trials of sodium valproate or divalproex sodium reported unambiguous data on the percentage of patients in active treatment groups who withdrew because of adverse events. These percentages ranged from 8% to 19% (<a href="./references#CD010611-bbs2-0002" title="FreitagFG , CollinsSD , CarlsonHA , GoldsteinJ , SaperJ , SilbersteinS , et al. A randomized trial of divalproex sodium extended‐release tablets in migraine prophylaxis. Neurology2002;58(11):1652‐9. [MEDLINE: 12058094] ">Freitag 2002</a>, 8%; <a href="./references#CD010611-bbs2-0004" title="JensenR , BrinckT , OlesenJ . Sodium valproate has a prophylactic effect in migraine without aura: a triple‐blind, placebo‐controlled crossover study. Neurology1994;44(4):647‐51. [MEDLINE: 8164818] ">Jensen 1994</a>, 9%; <a href="./references#CD010611-bbs2-0005" title="KanieckiRG . A comparison of divalproex with propanolol and placebo for the prophylaxis of migraine without aura. Archives of Neurology1997;54(9):1141‐5. [MEDLINE: 9311358] ">Kaniecki 1997</a>, 11%; <a href="./references#CD010611-bbs2-0007" title="KlapperJ , on behalf of the Divalproex Sodium in Migraine Prophylaxis Study Group. Divalproex sodium in migraine prophylaxis: a dose‐controlled study. Cephalalgia1997;17(2):103‐8. [MEDLINE: 9137847] ">Klapper 1997</a>, 19%; <a href="./references#CD010611-bbs2-0008" title="MathewNT , SaperJR , SilbersteinSD , RankinL , MarkleyHG , SolomonS , et al. Migraine prophylaxis with divalproex. Archives of Neurology1995;52(3):281‐6. [MEDLINE: 7872882] ">Mathew 1995</a>, 13%), with a mean of 12% (median 11%). </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010611-sec-0073" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010611-sec-0073"></div> <section id="CD010611-sec-0074"> <h3 class="title" id="CD010611-sec-0074">Summary of main results</h3> <section id="CD010611-sec-0075"> <h4 class="title">Placebo‐controlled trials</h4> <p>Meta‐analysis of the studies included in this review suggests that valproate is efficacious for the prophylaxis of migraine. Mean headache frequency was significantly reduced (by approximately four headaches per month) with sodium valproate as compared to placebo (two studies contributed to this analysis, one of which reported a baseline frequency of six headaches per month). Furthermore, and perhaps of greater clinical relevance (though less informative scientifically), patients were more than twice as likely to have a ≥ 50% reduction in headache frequency with divalproex sodium than with placebo (four studies contributed to this analysis). Supporting the latter finding, one small study showed that patients were nearly three times as likely to experience a ≥ 50% reduction in headache frequency with sodium valproate as with placebo. </p> </section> <section id="CD010611-sec-0076"> <h4 class="title">Dose comparisons</h4> <p>The data included did not demonstrate a direct dose‐response relationship.</p> </section> <section id="CD010611-sec-0077"> <h4 class="title">Trials with active comparators</h4> <p>The four trials using active comparators found (a) no significant difference in efficacy between sodium valproate and flunarizine (<a href="./references#CD010611-bbs2-0009" title="MitsikostasDD , PolychronidisI . Valproate versus flunarizine in migraine prophylaxis: a randomized, double‐open, clinical trial. Functional Neurology1997;12(5):267‐76. [MEDLINE: 9439944] ">Mitsikostas 1997</a>); (b) no significant difference in efficacy between divalproex sodium and propranolol (<a href="./references#CD010611-bbs2-0005" title="KanieckiRG . A comparison of divalproex with propanolol and placebo for the prophylaxis of migraine without aura. Archives of Neurology1997;54(9):1141‐5. [MEDLINE: 9311358] ">Kaniecki 1997</a>); and (c) a slight but significant advantage of topiramate over valproate (pooled results of <a href="./references#CD010611-bbs2-0001" title="AfshariD , RafizadehS , RezaeiM . A comparative study of the effects of low‐dose topiramate versus sodium valproate in migraine prophylaxis. International Journal of Neuroscience2012;122(2):60‐8. [MEDLINE: 21950578] ">Afshari 2012</a> and <a href="./references#CD010611-bbs2-0010" title="ShaygannejadV , JanghorbaniM , GhorbaniA , AshtaryF , ZakizadeN , NasrV . Comparison of the effect of topiramate and sodium valproate in migraine prevention: a randomized blinded crossover study. Headache2006;46(4):642‐8. [MEDLINE: 16643559] ">Shaygannejad 2006</a>). </p> </section> <section id="CD010611-sec-0078"> <h4 class="title">Safety</h4> <p>Valproate does not appear to give rise to an unexpectedly high rate of adverse events when used for migraine prophylaxis, although nausea is clearly a problem when trials of sodium valproate and divalproex sodium are considered together. </p> </section> </section> <section id="CD010611-sec-0079"> <h3 class="title" id="CD010611-sec-0079">Overall completeness and applicability of evidence</h3> <p>The studies identified were sufficient to address all of the objectives of the review. Our analysis demonstrates that valproate is efficacious for preventing attacks in adult patients with episodic migraine, and these results fit into the context of current practice. The trials with active comparator are of relevance since all three comparators have demonstrable efficacy in the prophylaxis of migraine (<a href="./references#CD010611-bbs2-0036" title="EdvinssonL , LindeM . New drugs in migraine treatment and prophylaxis: telcagepant and topiramate. Lancet2010;376(9741):645‐55. [MEDLINE: 20416945] ">Edvinsson 2010</a>; <a href="./references#CD010611-bbs2-0042" title="LindeK , RossnagelK . Propranolol for migraine prophylaxis. Cochrane Database of Systematic Reviews2004, Issue 2. [DOI: 10.1002/14651858.CD003225.pub2] ">Linde 2004</a>; <a href="./references#CD010611-bbs2-0053" title="Reveiz‐HeraultL , CardonaAF , OspinaEG , CarrilloP . Effectiveness of flunarizine in the prophylaxis of migraine: a meta‐analytical review of the literature [Eficacia de flunaricina en la profilaxis de migrana: revision metaanalitica de la bibliografia]. Revista de Neurologia2003;36(10):907‐12. [MEDLINE: 12766861] ">Reveiz‐Herault 2003</a>). </p> <p>Several important issues need to be taken into account in any assessment of the efficacy of a drug for migraine prophylaxis. Diagnostic criteria, baseline headache frequency, washout periods for previous medication, rules for rescue medication, and the statistical power of the comparison were handled very variably in the 10 included studies. As investigations of the efficacy of various agents become more commonplace, it seems increasingly important that scientists and clinicians are at least aware of the trial guidelines suggested by the International Headache Society (<a href="./references#CD010611-bbs2-0056" title="Tfelt‐HansenP , PascualJ , RamadanN , DahlöfC , D'AmicoD , DienerHC , et al. International Headache Society Clinical Trials Subcommittee. Guidelines for controlled trials of drugs in migraine: third edition. A guide for investigators. Cephalalgia2012;32(1):6‐38. [MEDLINE: 22384463] ">Tfelt‐Hansen 2012</a>). Even if these guidelines cannot — for operational or scientific reasons — be adhered to in their entirety, they provide a useful consultative framework at the early stages of trial design. </p> </section> <section id="CD010611-sec-0080"> <h3 class="title" id="CD010611-sec-0080">Quality of the evidence</h3> <p>The identified body of evidence allows a robust conclusion of an overall superiority of valproate over placebo with regard to reduction of mean headache frequency (two trials, 126 participants) and the proportion of responders (five trials, 576 participants). These relatively straightforward results should be viewed with some caution. As usual in the context of clinical trials research, there is considerable heterogeneity in both headline results and general levels of analytic and statistical sophistication. It is fair to say that we faced several difficulties in deriving adequate information from the results of the 10 included studies. It is appropriate, therefore, to review a number of caveats. The largest trial of divalproex sodium (<a href="./references#CD010611-bbs2-0002" title="FreitagFG , CollinsSD , CarlsonHA , GoldsteinJ , SaperJ , SilbersteinS , et al. A randomized trial of divalproex sodium extended‐release tablets in migraine prophylaxis. Neurology2002;58(11):1652‐9. [MEDLINE: 12058094] ">Freitag 2002</a>) did not report sufficient data for us to calculate mean differences (MDs) for headache frequency (means were reported, but not standard deviations (SDs)), but the analysis reported by the study investigators demonstrated a statistically significant (P = 0.006) difference favouring active treatment over placebo for this outcome. The clinical relevance of this effect was, however, less compelling, as both the investigators' analysis and our own found no significant difference between treatments in the proportion of responders (patients with ≥ 50% reduction in headache frequency). The finding of <a href="./references#CD010611-bbs2-0006" title="KinzeS , ClaussM , ReuterU , WolfT , DreierJP , EinhauplKM , et al. Valproic acid is effective in migraine prophylaxis at low serum levels: a prospective open‐label study. Headache2001;41(8):774‐8. [MEDLINE: 11576201] ">Kinze 2001</a>, that lower serum valproate levels produced lower headache frequency than higher serum levels, is somewhat counterintuitive, has not been replicated, and should be regarded as preliminary. It should be noted that all three trials with active comparator are potentially problematic for several reasons including lack of blinding. Further well‐designed trials of valproate against other active drugs and non‐pharmacological interventions are thus desirable. </p> </section> <section id="CD010611-sec-0081"> <h3 class="title" id="CD010611-sec-0081">Potential biases in the review process</h3> <p>Of 60 risk of bias items scored for the 10 studies, the majority of ratings were either 'unclear' (23 (38%)) or 'low' (20 (33%)) (<a href="#CD010611-fig-0001">Figure 1</a>; <a href="#CD010611-fig-0002">Figure 2</a>). As described in detail above (<a href="#CD010611-sec-0057">Risk of bias in included studies</a>), we judged seven trials as having a 'high' risk of bias for at least one item, as follows: random sequence generation (<a href="./references#CD010611-bbs2-0006" title="KinzeS , ClaussM , ReuterU , WolfT , DreierJP , EinhauplKM , et al. Valproic acid is effective in migraine prophylaxis at low serum levels: a prospective open‐label study. Headache2001;41(8):774‐8. [MEDLINE: 11576201] ">Kinze 2001</a>), allocation concealment (<a href="./references#CD010611-bbs2-0006" title="KinzeS , ClaussM , ReuterU , WolfT , DreierJP , EinhauplKM , et al. Valproic acid is effective in migraine prophylaxis at low serum levels: a prospective open‐label study. Headache2001;41(8):774‐8. [MEDLINE: 11576201] ">Kinze 2001</a>; <a href="./references#CD010611-bbs2-0009" title="MitsikostasDD , PolychronidisI . Valproate versus flunarizine in migraine prophylaxis: a randomized, double‐open, clinical trial. Functional Neurology1997;12(5):267‐76. [MEDLINE: 9439944] ">Mitsikostas 1997</a>), blinding of participants and personnel (<a href="./references#CD010611-bbs2-0001" title="AfshariD , RafizadehS , RezaeiM . A comparative study of the effects of low‐dose topiramate versus sodium valproate in migraine prophylaxis. International Journal of Neuroscience2012;122(2):60‐8. [MEDLINE: 21950578] ">Afshari 2012</a>; <a href="./references#CD010611-bbs2-0005" title="KanieckiRG . A comparison of divalproex with propanolol and placebo for the prophylaxis of migraine without aura. Archives of Neurology1997;54(9):1141‐5. [MEDLINE: 9311358] ">Kaniecki 1997</a>; <a href="./references#CD010611-bbs2-0006" title="KinzeS , ClaussM , ReuterU , WolfT , DreierJP , EinhauplKM , et al. Valproic acid is effective in migraine prophylaxis at low serum levels: a prospective open‐label study. Headache2001;41(8):774‐8. [MEDLINE: 11576201] ">Kinze 2001</a>; <a href="./references#CD010611-bbs2-0009" title="MitsikostasDD , PolychronidisI . Valproate versus flunarizine in migraine prophylaxis: a randomized, double‐open, clinical trial. Functional Neurology1997;12(5):267‐76. [MEDLINE: 9439944] ">Mitsikostas 1997</a>), blinding of outcome assessment (<a href="./references#CD010611-bbs2-0005" title="KanieckiRG . A comparison of divalproex with propanolol and placebo for the prophylaxis of migraine without aura. Archives of Neurology1997;54(9):1141‐5. [MEDLINE: 9311358] ">Kaniecki 1997</a>; <a href="./references#CD010611-bbs2-0006" title="KinzeS , ClaussM , ReuterU , WolfT , DreierJP , EinhauplKM , et al. Valproic acid is effective in migraine prophylaxis at low serum levels: a prospective open‐label study. Headache2001;41(8):774‐8. [MEDLINE: 11576201] ">Kinze 2001</a>; <a href="./references#CD010611-bbs2-0009" title="MitsikostasDD , PolychronidisI . Valproate versus flunarizine in migraine prophylaxis: a randomized, double‐open, clinical trial. Functional Neurology1997;12(5):267‐76. [MEDLINE: 9439944] ">Mitsikostas 1997</a>), incomplete outcome data (<a href="./references#CD010611-bbs2-0003" title="HeringR , KuritzkyA . Sodium valproate in the prophylactic treatment of migraine: a double‐blind study versus placebo. Cephalalgia1992;12(2):81‐4. [MEDLINE: 1576648] ">Hering 1992</a>; <a href="./references#CD010611-bbs2-0004" title="JensenR , BrinckT , OlesenJ . Sodium valproate has a prophylactic effect in migraine without aura: a triple‐blind, placebo‐controlled crossover study. Neurology1994;44(4):647‐51. [MEDLINE: 8164818] ">Jensen 1994</a>; <a href="./references#CD010611-bbs2-0005" title="KanieckiRG . A comparison of divalproex with propanolol and placebo for the prophylaxis of migraine without aura. Archives of Neurology1997;54(9):1141‐5. [MEDLINE: 9311358] ">Kaniecki 1997</a>; <a href="./references#CD010611-bbs2-0006" title="KinzeS , ClaussM , ReuterU , WolfT , DreierJP , EinhauplKM , et al. Valproic acid is effective in migraine prophylaxis at low serum levels: a prospective open‐label study. Headache2001;41(8):774‐8. [MEDLINE: 11576201] ">Kinze 2001</a>; <a href="./references#CD010611-bbs2-0009" title="MitsikostasDD , PolychronidisI . Valproate versus flunarizine in migraine prophylaxis: a randomized, double‐open, clinical trial. Functional Neurology1997;12(5):267‐76. [MEDLINE: 9439944] ">Mitsikostas 1997</a>), and/or selective reporting (<a href="./references#CD010611-bbs2-0006" title="KinzeS , ClaussM , ReuterU , WolfT , DreierJP , EinhauplKM , et al. Valproic acid is effective in migraine prophylaxis at low serum levels: a prospective open‐label study. Headache2001;41(8):774‐8. [MEDLINE: 11576201] ">Kinze 2001</a>; <a href="./references#CD010611-bbs2-0007" title="KlapperJ , on behalf of the Divalproex Sodium in Migraine Prophylaxis Study Group. Divalproex sodium in migraine prophylaxis: a dose‐controlled study. Cephalalgia1997;17(2):103‐8. [MEDLINE: 9137847] ">Klapper 1997</a>) (<a href="#CD010611-fig-0002">Figure 2</a>). A strength of this review is that the methods used for searching and study selection make it highly likely that the absolute majority of relevant trial results in the public domain were identified. There is nevertheless an obvious risk that the reports of some trials may have been classified and thus remain unobtainable. </p> </section> <section id="CD010611-sec-0082"> <h3 class="title" id="CD010611-sec-0082">Agreements and disagreements with other studies or reviews</h3> <p>The overall conclusion in this review, that valproate is efficacious for preventing attacks in adult patients with episodic migraine, is well in line with guideline recommendations of the EFNS (<a href="./references#CD010611-bbs2-0037" title="EversS , AfraJ , FreseA , GoadsbyPJ , LindeM , MayA , et al. European Federation of Neurological Societies. EFNS guideline on the drug treatment of migraine—revised report of an EFNS task force. European Journal of Neurology2009;16(9):968‐81. [MEDLINE: 19708964] ">Evers 2009</a>) and the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society (<a href="./references#CD010611-bbs2-0055" title="SilbersteinSD , HollandS , FreitagF , DodickDW , ArgoffC , AshmanE , Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Evidence‐based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology2012;78(17):1337‐45. [MEDLINE: 22529202] ">Silberstein 2012</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010611-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/urn:x-wiley:14651858:media:CD010611:CD010611-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_t/tCD010611-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010611-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_n/nCD010611-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010611/full#CD010611-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_n/nCD010611-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010611-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/urn:x-wiley:14651858:media:CD010611:CD010611-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_t/tCD010611-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010611-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_n/nCD010611-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010611/full#CD010611-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_n/nCD010611-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010611-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/urn:x-wiley:14651858:media:CD010611:CD010611-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_t/tCD010611-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Divalproex sodium versus placebo, Outcome 1 ORs for responders (patients with ≥ 50% reduction in headache frequency)." data-id="CD010611-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_n/nCD010611-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Divalproex sodium versus placebo, Outcome 1 ORs for responders (patients with ≥ 50% reduction in headache frequency). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010611/references#CD010611-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_n/nCD010611-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010611-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/urn:x-wiley:14651858:media:CD010611:CD010611-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_t/tCD010611-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Divalproex sodium versus placebo, Outcome 2 RRs for responders (patients with ≥ 50% reduction in headache frequency)." data-id="CD010611-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_n/nCD010611-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Divalproex sodium versus placebo, Outcome 2 RRs for responders (patients with ≥ 50% reduction in headache frequency). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010611/references#CD010611-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_n/nCD010611-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010611-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/urn:x-wiley:14651858:media:CD010611:CD010611-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_t/tCD010611-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Sodium valproate versus placebo, Outcome 1 Headache frequency (post‐treatment)." data-id="CD010611-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_n/nCD010611-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Sodium valproate versus placebo, Outcome 1 Headache frequency (post‐treatment).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010611/references#CD010611-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_n/nCD010611-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010611-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/urn:x-wiley:14651858:media:CD010611:CD010611-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_t/tCD010611-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Sodium valproate versus placebo, Outcome 2 ORs for responders (patients with ≥ 50% reduction in headache frequency)." data-id="CD010611-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_n/nCD010611-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Sodium valproate versus placebo, Outcome 2 ORs for responders (patients with ≥ 50% reduction in headache frequency). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010611/references#CD010611-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_n/nCD010611-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010611-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/urn:x-wiley:14651858:media:CD010611:CD010611-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_t/tCD010611-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Sodium valproate versus placebo, Outcome 3 RRs for responders (patients with ≥ 50% reduction in headache frequency)." data-id="CD010611-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_n/nCD010611-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Sodium valproate versus placebo, Outcome 3 RRs for responders (patients with ≥ 50% reduction in headache frequency). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010611/references#CD010611-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_n/nCD010611-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010611-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/urn:x-wiley:14651858:media:CD010611:CD010611-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_t/tCD010611-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Sodium valproate dose comparisons, Outcome 1 Headache frequency (post‐treatment)." data-id="CD010611-fig-0008" src="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_n/nCD010611-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Sodium valproate dose comparisons, Outcome 1 Headache frequency (post‐treatment).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010611/references#CD010611-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_n/nCD010611-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010611-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/urn:x-wiley:14651858:media:CD010611:CD010611-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_t/tCD010611-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Sodium valproate versus flunarizine, Outcome 1 Responders (patients with ≥ 50% reduction in headache frequency)." data-id="CD010611-fig-0009" src="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_n/nCD010611-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Sodium valproate versus flunarizine, Outcome 1 Responders (patients with ≥ 50% reduction in headache frequency). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010611/references#CD010611-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_n/nCD010611-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010611-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/urn:x-wiley:14651858:media:CD010611:CD010611-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_t/tCD010611-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Divalproex sodium versus propanolol, Outcome 1 Responders (patients with ≥ 50% reduction in headache frequency)." data-id="CD010611-fig-0010" src="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_n/nCD010611-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Divalproex sodium versus propanolol, Outcome 1 Responders (patients with ≥ 50% reduction in headache frequency). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010611/references#CD010611-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_n/nCD010611-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010611-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/urn:x-wiley:14651858:media:CD010611:CD010611-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_t/tCD010611-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Sodium valproate versus topiramate, Outcome 1 Headache frequency (post‐treatment)." data-id="CD010611-fig-0011" src="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_n/nCD010611-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Sodium valproate versus topiramate, Outcome 1 Headache frequency (post‐treatment).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010611/references#CD010611-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_n/nCD010611-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010611-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/urn:x-wiley:14651858:media:CD010611:CD010611-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_t/tCD010611-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Sodium valproate versus topiramate, Outcome 2 MIDAS score." data-id="CD010611-fig-0012" src="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_n/nCD010611-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Sodium valproate versus topiramate, Outcome 2 MIDAS score.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010611/references#CD010611-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_n/nCD010611-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010611-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/urn:x-wiley:14651858:media:CD010611:CD010611-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_t/tCD010611-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Safety of sodium valproate and divalproex sodium versus placebo, Outcome 1 Any adverse event." data-id="CD010611-fig-0013" src="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_n/nCD010611-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Safety of sodium valproate and divalproex sodium versus placebo, Outcome 1 Any adverse event. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010611/references#CD010611-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_n/nCD010611-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010611-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/urn:x-wiley:14651858:media:CD010611:CD010611-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_t/tCD010611-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Safety of sodium valproate and divalproex sodium versus placebo, Outcome 2 Asthenia/fatigue." data-id="CD010611-fig-0014" src="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_n/nCD010611-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 Safety of sodium valproate and divalproex sodium versus placebo, Outcome 2 Asthenia/fatigue. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010611/references#CD010611-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_n/nCD010611-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010611-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/urn:x-wiley:14651858:media:CD010611:CD010611-CMP-007-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_t/tCD010611-CMP-007-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Safety of sodium valproate and divalproex sodium versus placebo, Outcome 3 Dizziness/vertigo." data-id="CD010611-fig-0015" src="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_n/nCD010611-CMP-007-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7 Safety of sodium valproate and divalproex sodium versus placebo, Outcome 3 Dizziness/vertigo. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010611/references#CD010611-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_n/nCD010611-CMP-007-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010611-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/urn:x-wiley:14651858:media:CD010611:CD010611-CMP-007-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_t/tCD010611-CMP-007-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Safety of sodium valproate and divalproex sodium versus placebo, Outcome 4 Nausea." data-id="CD010611-fig-0016" src="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_n/nCD010611-CMP-007-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.4</div> <div class="figure-caption"> <p>Comparison 7 Safety of sodium valproate and divalproex sodium versus placebo, Outcome 4 Nausea. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010611/references#CD010611-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_n/nCD010611-CMP-007-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010611-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/urn:x-wiley:14651858:media:CD010611:CD010611-CMP-007-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_t/tCD010611-CMP-007-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Safety of sodium valproate and divalproex sodium versus placebo, Outcome 5 Tremor." data-id="CD010611-fig-0017" src="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_n/nCD010611-CMP-007-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.5</div> <div class="figure-caption"> <p>Comparison 7 Safety of sodium valproate and divalproex sodium versus placebo, Outcome 5 Tremor. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010611/references#CD010611-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_n/nCD010611-CMP-007-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010611-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/urn:x-wiley:14651858:media:CD010611:CD010611-CMP-007-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_t/tCD010611-CMP-007-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Safety of sodium valproate and divalproex sodium versus placebo, Outcome 6 Weight gain." data-id="CD010611-fig-0018" src="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_n/nCD010611-CMP-007-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.6</div> <div class="figure-caption"> <p>Comparison 7 Safety of sodium valproate and divalproex sodium versus placebo, Outcome 6 Weight gain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010611/references#CD010611-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010611/media/CDSR/CD010611/image_n/nCD010611-CMP-007-06.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="comparison" data-id="CD010611-tbl-0001"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Divalproex sodium versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 ORs for responders (patients with ≥ 50% reduction in headache frequency) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>574</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.34 [1.46, 7.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Divalproex sodium titrated to 1500 mg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.68 [1.98, 16.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Divalproex sodium titrated to maintain plasma concentration of 70 to 120 mg/L (mean 1087 mg/day) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.27 [2.62, 26.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Divalproex sodium titrated to 500 mg or 1000 mg/day, as tolerated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>234</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.35 [0.76, 2.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Divalproex sodium 500 mg, 1000 mg, or 1500 mg/day (combined results)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>171</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.90 [1.29, 6.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 RRs for responders (patients with ≥ 50% reduction in headache frequency) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>574</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.18 [1.28, 3.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Divalproex sodium titrated to 1500 mg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.44 [1.47, 8.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Divalproex sodium titrated to maintain plasma concentration of 70 to 120 mg/L (mean 1087 mg/day) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.5 [1.63, 7.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Divalproex sodium titrated to 500 mg or 1000 mg/day, as tolerated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>234</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [0.81, 1.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 Divalproex sodium 500 mg, 1000 mg, or 1500 mg/day (combined results)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>171</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.06 [1.12, 3.80]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Divalproex sodium versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010611/references#CD010611-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010611-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Sodium valproate versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Headache frequency (post‐treatment) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>126</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.31 [‐8.32, ‐0.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Sodium valproate 1000 mg or 1500 mg/day (to maintain plasma concentration above 50 mg/L) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.60 [‐4.07, ‐1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Sodium valproate 800 mg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.76 [‐10.51, ‐3.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 ORs for responders (patients with ≥ 50% reduction in headache frequency) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Sodium valproate 1000 mg or 1500 mg/day (to maintain plasma concentration above 50 mg/L) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 RRs for responders (patients with ≥ 50% reduction in headache frequency) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Sodium valproate 1000 mg or 1500 mg/day (to maintain plasma concentration above 50 mg/L) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Sodium valproate versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010611/references#CD010611-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010611-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Sodium valproate dose comparisons</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Headache frequency (post‐treatment) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Sodium valproate dose comparisons</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010611/references#CD010611-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010611-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Sodium valproate versus flunarizine</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Responders (patients with ≥ 50% reduction in headache frequency) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Sodium valproate versus flunarizine</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010611/references#CD010611-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010611-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Divalproex sodium versus propanolol</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Responders (patients with ≥ 50% reduction in headache frequency) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Divalproex sodium versus propanolol</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010611/references#CD010611-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010611-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Sodium valproate versus topiramate</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Headache frequency (post‐treatment) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.90 [‐1.58, ‐0.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 MIDAS score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Sodium valproate versus topiramate</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010611/references#CD010611-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010611-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Safety of sodium valproate and divalproex sodium versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Any adverse event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>499</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.08, 0.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Asthenia/fatigue <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>606</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [‐0.03, 0.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Dizziness/vertigo <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>262</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [0.01, 0.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>606</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.15 [0.04, 0.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Tremor <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>369</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [0.01, 0.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Weight gain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Safety of sodium valproate and divalproex sodium versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010611/references#CD010611-tbl-0007">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010611&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD010611-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010611-note-0005">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD010611-note-0002">Français</a> </li> <li class="section-language"> <a class="" href="ko#CD010611-note-0001">한국어</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br/> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010611\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010611\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010611\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010611"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010611\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010611\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010611\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010611\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010611\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010611"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010611\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010611\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010611\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010611"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010611\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010611\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010611\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010611"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=f00EizoA&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010611&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010611';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010611/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010611/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010611%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740727874237"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010611/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740727874241"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010611/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918eb6b67dd49368',t:'MTc0MDcyNzg3NC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 